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INTRODUCTION 
SCHISTOSOMIASIS AND CHEMOTHERAPY 
 Parasitic platyhelminths (flatworms), both flukes and tapeworms, infect a 
variety of vertebrates, including humans, pets and production animals. The number 
of existing anthelmintic drugs is few and there is an ongoing concern that parasites 
are developing resistance to available drugs, making the potential choices even 
fewer. The discovery of a new generation of anthelmintics able to fight infections 
caused by the blood fluke Schistosoma mansoni is very urgent and at least in part 
limited by the lack of our knowledge of basic parasite biology and physiology. 
Human schistosomiasis is principally caused by one of the six species of 
parasitic worms, Schistosoma mansoni, S. haematobium, S. intercalatum, S. 
malayensis, S. japonicum and S. mekongi. Schistosomiasis caused by S. mansoni 
and S. japonicum is the most abundant. Schistosomes are blood flukes that belong 
to the phylum Platyhelminthes, class Trematoda, which require a vertebrate and a 
snail host for completion of their life cycle. Endemic areas and transmission of the 
disease are limited by available snail hosts. Currently there are more than 200 
million people infected with human schistosomiasis in 74 countries worldwide, 
mostly in tropic regions of Africa, East Asia, Middle East, China, and South America. 
Mortality from the disease is mostly caused by “fibro-occlusive disease secondary to 
the immune stimulus of schistosome eggs and end organ damage” (Kheir et al., 
1999; Wynn et al., 2004). 
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Treatment choices nowadays are confined to praziquantel (a 
pyrazinoquinolone). Praziquantel has proved to be very effective against five of six 
Schistosoma species. However, there have been ongoing reports suggesting 
increasing resistance of the parasite to it (Ismail et al., 1999; William et al., 2001), 
heightening the urgency for the development of new treatment options. It has been 
reported that anti-malarial drug artesunate has some efficacy against urinary 
schistosomiasis in humans (Inyang-Etoh et al., 2004) and experimental S. mansoni 
infection in mice (Shaohong et al., 2006), but its use raises a concern that 
widespread use of the drug against schistosomiasis can lead to resistance in 
plasmodium. 
There is a widespread agreement in the parasitology and public health 
communities that new anti-schistosomal drugs are urgently needed. One of the most 
suitable places to look for new targets for anthelmintic drugs is the neuromuscular 
system. 
Physiology and pharmacology of flatworm muscle can be studied using intact 
live animals, muscle strip preparations or dissociated muscle fiber preparations (Day 
et al., 1994; Graham et al., 2000; Blair et al., 1994). With the development of an 
isolated muscle preparation (Blair et al., 1991; Day et al., 1994), where muscle fibers 
are deprived of any neural input, it became possible to directly test pharmacological 
agents’ effects on the muscle, and to do patch-clamp studies on individual muscle 
fibers. In this preparation, individual muscle fibers are dispersed using a combination 
of enzymatic and mechanical disruption, yielding accessible contractile muscle fibers 
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for further study (Mendonça-Silva et al., 2006; Miller et al., 1996; Cobbett and Day, 
2003; Day et al., 1994; Moneypenny et al., 2001). 
The search for vulnerable targets for drug therapy in the flatworm has led 
scientists to investigate neurotransmission mediated by neuropeptides as a possible 
option for drug intervention (Day and Maule, 1999). Neuropeptides are abundant 
intercellular signaling molecules throughout the invertebrates, but many of these 
signaling molecules have no known structural correlates amongst mammals. 
Elucidation of the pathways employed by neuropeptides in the parasitic flatworm 
muscle can serve as a valuable tool in search of new drug target options. Since 
parasite maintenance in the laboratory setting can be very hazardous, laborious and 
expensive, model organisms can be used as a pilot study for developing appropriate 
experimental protocols. 
SCHMIDTEA MEDITERRANEA AS A MODEL ORGANISM 
Schmidtea mediterranea as a model for regeneration 
Extensive studies of stem cell biology, regeneration and tissue homeostasis 
face inability of current model systems like Drosophila melanogaster and 
Caenorhabditis elegans to fully address these fundamental biological processes. 
Both models proved to be not fully suitable for these studies due to short lifespans, 
lack of tissue regeneration and adult somatic stem cells (Sánchez Alvarado 2004; 
Reddien et al., 2005). Also they were found to be not completely amenable to 
modern RNA interference techniques (Sánchez Alvarado 2006). A new model 
invertebrate system needed to be introduced for more fulfilling studies. Regenerative 
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capacity of planarians was known for over a hundred years (Reddien et al., 2005). 
The planarian S. mediterranea has emerged as an attractive model system since it 
meets major requirements for being a model organism. It is one of simplest 
metazoans with well-manifested properties of interest, primarily powerful 
regenerative properties. It is also easy to maintain and explore in a laboratory setting 
(Sánchez Alvarado 2004). Being a stable diploid (2n=8) with a genome size of 4.8 x 
108 basepairs (Sánchez Alvarado 2006) makes S. mediterranea very advantageous 
among other planarian species, very few of which are stably diploid. Tissues of adult 
planarians undergo extensive turnover (Reddien et al., 2005) and body parts lost to 
injury are regenerated as a result of neoblast division. Neoblasts are a population of 
totipotent adult somatic stem cells distributed all over the organism (Palakodeti et al., 
2006; Sánchez Alvarado 2004; Reddien et al., 2005). Replacement of aged and 
damaged cells is poorly understood, but with advent of extensive genetic 
manipulation S. mediterranea can serve to determine the molecular and cell biology 
of regeneration in higher animals (Reddien et al., 2005, Palakodeti et al., 2006; 
Kiefer 2006), which cannot be addressed using current invertebrate models 
(Sánchez Alvarado 2006). 
Tools for studying regeneration processes in S. mediterranea have been 
developed (Sánchez Alvarado and Newmark, 1999). Among them are neoblast 
labeling methods, the creation of cDNA collections and exploration of planarian 
genes by mutant screens and use of RNA interference to disrupt gene function. 
Recent sequencing and ongoing assembly of S. mediterranea genome resulted in 
the creation of S. mediterranea Genome Database (SmedGD) (Robb et al., 2008). 
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Use of dsRNA technology in S. mediterranea provided insight into molecular 
activities responsible for biological function. Large scale gene inhibition experiments 
produced RNAi phenotypes of 240 genes that are responsible for many specific 
defects in regeneration, 85% of which are conserved in other organisms and encode 
significantly homologous proteins (Reddien et al., 2005). Clear understanding of 
gene function related to regeneration in this animal will shed light on the biology of 
regeneration in higher animals. 
Schmidtea mediterranea as a model for parasitic platyhelminths 
S. mediterranea as a tractable model for developmental biology can also be 
beneficial for studies done within the phylum Platyhelminthes itself. Elucidation of 
the S. mediterranea genome opened possibilities to discover critical components of 
neural signaling in these animals as well as in their parasitic counterparts. 
Neurotransmission mediated by FMRFamide-like peptides (FaRPs or FLPs) has 
been proposed as a potential drug target for novel anthelmintics (Day and Maule, 
1999). Neuropeptides are abundant intercellular signaling molecules throughout the 
invertebrates, and many of these signaling molecules have no known structural 
correlates amongst mammals. Some of the FLP sequences are known while lots 
more are still to be discovered. Search for new FLPs candidates besides isolation 
from species includes genomics approach, when FLPs in a particular species are 
predicted from their genome sequence based on genome comparison with other 
species with known FLPs. 
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Physiology of flatworm muscle and a role of the complement of voltage-
operated channels in it can also be addressed using S. mediterranea as a model 
flatworm. Voltage-operated Ca2+ channels (VOCCs) are of interest since Ca2+ 
signaling is important in the physiology of muscle. Despite the fact that the presence 
of VOCCs in both free-living and parasitic flatworms has been evident from 
molecular data (Kohn et al., 2001), it has been difficult in flatworms to record the 
inward currents carried by these channels, and even more difficult to perform their 
pharmacological characterization. 
VOLTAGE-OPERATED Ca2+ CHANNELS IN VERTEBRATES 
VOCCs structure and classification 
Voltage-operated Ca2+ channels (VOCCs) play important roles in excitable 
cells by coupling changes in the membrane potential to intracellular Ca2+-activated 
events such as muscle contraction, secretion, neurotransmitter release, stimulation 
of second messenger systems and regulation of gene expression. Since different 
physiological responses are linked to different patterns of Ca2+ entry, a variety of 
channels exists, which depending on channel type and specific properties provide 
specific pattern of Ca2+ fluxes. In vertebrates, various classes of VOCCs are defined 
by: 1) molecular characterization of channel subunits; 2) electrophysiological criteria, 
such as the magnitude of depolarizing voltage step required for activation, the time 
course of inactivation, the magnitude of the conductance of a single calcium 
channel; and 3) pharmacological criteria based on their sensitivity to 
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dihydropyridines and ω-toxins (Lipscombe et al., 2004; Skeer et al., 1992; Olivera et 
al., 1994; Mintz et al., 1992; Kasai and Neher, 1992). 
Molecular data show that VOCCs consist of a pore-forming α1 subunit, 
auxiliary β and α2δ, as well as γ subunits (Witcher et al., 1993; Curtis and Catterall, 
1984). Most channel diversity arises from α1 subunits. The α1 subunit has been 
shown to be responsible for channel formation and pore selectivity (Takahashi et al., 
1987; Ertel et al., 2000), sensing of transmembrane voltage (De Jongh et al., 1989; 
Ertel et al., 2000) and presence of sites of channel regulation by drugs, toxins and 
second messengers (Ertel et al., 2000; Regulla et al., 1991). While α1 is crucial for 
pore selectivity, auxiliary subunits, mostly β, can determine the particular properties 
of Ca2+ channel, such as activation and inactivation kinetics, increased current 
amplitudes and the presence of specific sites allowing channel control by 
intracellular mechanisms (Varadi et al., 1991; Arias 2006; Neely et al., 1993; Reimer 
et al., 2000; Hohaus et al., 2000). The γ-subunit plays modulator roles of channel 
complex and is found in skeletal muscle and also in heart and in the brain (Ertel et 
al., 2000). At least ten different genes encoding α1 subunits have been identified, 
which set the grounds for a classification based on their sequence similarity, which 
within each group is represented by more than 70 % sequence similarity (Ertel et al., 
2000): Cav1, Cav2 and Cav3 (Table 1). 
Electrophysiologically, vertebrate VOCCs are divided into two major groups: 
high voltage-activated (HVA) and low voltage-activated (LVA). HVA (Cav1 and Cav2) 
Ca2+ channels are slowly inactivating with larger conductances. They require 
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relatively strong depolarization for their activation, which limits their involvement to 
processes that are triggered by strong and sustained depolarizations. LVA (Cav3) 
Ca2+ channels are rapidly inactivating channels with smaller conductances and 
require less depolarization for activation. 
Currents carried by HVA channels can be further subdivided into 
dihydropyridine (DHP)-sensitive (L-type) and DHP-insensitive (non-L-type). Non-L-
type HVA channels are further classified based on their sensitivity to toxins (Table 
1). The ω-conotoxin GVIA blocks N-type channels in mammalian neurons (Kasai 
and Neher, 1992) and the synthetic analog of funnel-web toxin (sFTX) is a selective 
blocker of T-type channels in rat dorsal ganglion cells (Lin et al., 1990). 
Besides sensitivity to DHPs, vertebrate L-channels are blocked by 
phenylalkyalamines (PAA) such as verapamil (Triggle and Janis, 1987) and are 
sensitive to ω-AgaIIIA toxin (Cohen et al., 1992). 
Subunits forming Ca2+ channels have tissue-specific expression (Angelotti 
and Hofmann, 1996; Reimer et al., 2000). The α1S gene is expressed in the skeletal 
muscle and forms a channel which acts as a voltage sensor and couples 
depolarization to contraction by means of Ca2+-induced Ca2+ release (CICR) from 
the sarcoendoplasmic reticulum (SR) via ryanodine receptor activation (Tanabe et 
al., 1988; Xu et al., 2008; Ríos and Pizarro, 1991). The α1C gene is expressed in 
different tissues, including smooth muscle (Yokoyama et al., 2006; Boyer et al., 
2001; Reimer et al., 2000; Hohaus et al., 2000), cardiac muscle (Hullin et al., 1999; 
Schroder et al., 2007) as well as in osteoblasts and neuronal tissue (Bergh et al., 
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2003; Striessnig et al., 2006). Here the Ca2+ channel operates as an ion channel and 
allows calcium influx, which triggers cardiac or smooth muscle contraction (Zhang et 
al., 2007; Chen et al., 2005). The α1D gene is co-expressed with the α1C in 
cardiovascular tissues (Marcantoni et al., 2007) and also forms a channel 
responsible for synaptic transmission control in inner hair cells, adrenal chromaffin 
cells and photoreceptors (Johnson and Marcotti, 2008; Marcantoni et al., 2007; Wu 
et al., 2007). The α1F subunit has been shown to assemble the retinal specific L-type 
channel (Vigh and Lasater, 2004). 
Within the mammalian system, the molecular-based classification is in good 
accordance to groups formed on similar physiological and pharmacological profiles: 
L-type (Cav1); N-, P/Q-, R-type (Cav2) and T-type (Cav3). However channels from 
different groups have been shown to overlap in voltage dependence and inactivation 
kinetics (Regan et al., 1991). The ability for activation at lower voltages should not 
be solely attributed to the family of T-type class Ca2+ channels, since studies in 
cochlea inner hair cells, pancreatic β-cells and in neuronal tissue (Koschak et al., 
2001; Scholze et al., 2001; Xu and Lipscombe, 2001) have demonstrated presence 
of low-voltage-activated with fast kinetics neuronal L-type Ca2+ channels, belonging 
to Cav1.3 family (Lipscombe et al., 2004). The studied L-type Ca2+ channels formed 
by α1D subunits had produced currents that activated at more negative voltages as 
compared to the rest of the family, had different inactivation kinetics, and had the 
same or decreased sensitivity to DHPs.
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Table 1. Classification of vertebrate voltage-operated Ca2+ channels. 
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Vertebrate Ca currents 
High-Voltage Activated (HVA) 
 
Low-Voltage 
Activated 
(LVA) 
DHP-sensitive DHP-insensitive 
Blocked by ω-
conotoxin GVIA and 
ω-conotoxin MVIIA 
 
Blocked by ω-
conotoxin MVIIC 
+ ω-agatoxin IVA 
 
Toxin-resistant 
 
 
 
 
Non L-type (Cav2) 
L-type (Cav1) 
(resistant to ω-
toxins, sensitive to 
ω-AgaIIIA toxin) 
Cav1.1 (α1S) Skeletal 
muscle 
Cav1.2 (α1C) Heart, 
smooth muscle, 
brain, pituitary, 
adrenal 
Cav1.3 (α1D) Brain, 
pancreas, kidney, 
ovary, cochlea 
Cav1.4 (α1F) Retina 
N-type 
Cav2.2 (α1B) 
Neurons (peripheral 
and CNS); 
Mediate 
neurotransmitter 
release at synaptic 
endings. 
 
 
 
P/Q-type 
Cav2.1 (α1A) 
Central and 
peripheral 
neurons; synaptic 
terminals; 
Purkinje neuron 
cell bodies; 
Cochlea; 
Pituitary. 
R-type 
Cav2.3 (α1E) Brain 
(soma and proximal 
neuron dendrites); 
Retina; Heart; 
Cochlea; Pituitary. 
 
 
 
 
 
 
T-type (Cav3) 
Cav3.1 (α1G) Brain, 
nervous system 
Cav3.2 (α1H) Brain, 
heart, kidney, liver. 
Cav3.3 (α1I) Brain 
 
 
 
 
 
Table 1 
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VOCC mechanisms of regulation 
L-type channels may be controlled by a wide range of mechanisms. 
Regulation of L-type Ca2+ channels can be voltage-dependent and voltage-
independent (Marcantoni et al., 2007; Carbone et al., 2001). Voltage-dependent 
modulation includes facilitation (by strong and long-lasting prepulses) and fast cAMP 
(cyclic adenosine monophosphate) / protein kinase A (PKA)-mediated 
phosphorylation favored by strong depolarizations. 
Voltage-dependent facilitation of L-type channels results in increased current 
amplitudes due to long channel openings and high probability of being open in 
cardiac and skeletal muscle (Pietrobon and Hess, 1990; Ma et al., 1996; Kleppisch 
et al., 1994) as well as in neuronal and neuroendocrine tissues (Hoshi et al., 1984; 
Kammermeier and Jones, 1998). In the case of N- and P-/Q-types of channels, 
voltage-dependent facilitation reduces the delayed transition caused by 
neurotransmitters from modified to a facilitated gating mode (Carabelli et al., 1996) 
and involves dissociation of a Goβγ subunit from the channel (Herlitze et al., 1996; 
Boland and Bean, 1993). In ganglion and sympathetic neurons a phosphorylation 
mechanism involving protein kinase C (PKC) has been shown to prevent G-protein-
mediated inhibition without any other effect (Barrett and Rittenhouse, 2000; Zhu and 
Ikeda, 1994). 
The cAMP/PKA-mediated phosphorylation favored by strong depolarizations 
has been reported for neuroendocrine cells (Artalejo et al., 1990; Artalejo et al., 
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1991; Carbone et al., 2001), skeletal muscle (Johnson et al., 1997; Johnson et al., 
1994) and neurons (Sculptoreanu et al., 1995). 
Voltage-independent L-type Ca2+ channel regulation comprises potentiation 
by increased cAMP levels and inhibition by Gi/o. Inhibition by Gi/o is mainly confined 
to α1D and α1C subunits, expressed in neuronal and neuroendocrine cells, where 
current scale down with no change in the activation course is triggered by 
neurotransmitters and is direct membrane-delimited (Albillos et al., 1996; Carbone et 
al., 2001; Carabelli et al., 1998; Hernández-Guijo et al., 1999). On the contrary to L-
type channels, inhibition by Gi/o of N- and P-/Q-type channels is voltage-dependent 
(Carbone et al., 2001). 
Cardiac muscle L-type Ca2+ channel potentiation by increased cAMP levels 
requires β1-adrenergic stimulation or application of cAMP permeable analogs to 
activate protein kinase A (PKA), which phosphorylates the channel and increases its 
open probability resulting in increased current amplitude (Bean et al., 1984). 
Channel regulation may be possible due to the intrinsic property of α1 subunit, 
or may require involvement of other subunits. Voltage-dependent facilitation in case 
of smooth and cardiac muscle α1C has been reported without the requirement of β 
subunits (Kleppisch et al., 1994; Lee et al., 2006), while in some cases their co-
expression is obligatory for the proper channel regulation (Bourinet et al., 1994; 
Kamp et al., 2000; Platano et al., 2000; Cens et al., 1996). Out of four subunits (β1, 
β2, β3 and β4), only β2 is not permissive for Ca2+ channel facilitation (Cens et al., 
1996; Carbone et al., 2001). Different regulatory outcomes seem to be attributed to 
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the ability of β subunits to affect the relationship of the gating charge movement and 
channel opening (Neely et al., 1993; Olcese et al., 1996). 
VOLTAGE-OPERATED Ca2+ CHANNELS IN INVERTEBRATES 
In invertebrates the tight link between molecular and pharmacological identity 
is not well maintained, thus making it hard to render a particular channel as being L- 
or non-L-type according to both molecular and pharmacological profiles. Amongst 
invertebrates both L- and non-L-type α1 subunits have been cloned from flatworms 
S. mansoni (Kohn et al., 2001) and Bdelloura candida (Greenberg et al., 1995), the 
nematode C. elegans (Lee et al., 1997; Schafer and Kenyon, 1995), the fruit fly D. 
melanogaster (Zheng et al., 1995; Smith et al., 1996), and a cockroach Blatella 
germanica (Inagaki et al., 1998), amongst others. Only T-type α1 subunit cloned so 
far is from C. elegans system (Jeziorski et al., 2000). HVA β subunits have been 
cloned from S. mansoni (Kohn et al., 2001b), the pearl oyster Pinctada fucata (Fan 
et al., 2007), a squid Loligo bleekeri (Kimura and Kubo, 2003) and C. elagans 
(Jeziorski et al., 2000). 
Invertebrate Ca2+ channels have different pharmacological properties as 
compared to their vertebrate counterparts, with most of the difficulty arising in trying 
to define pharmacological separation between L- and N-types (Table 2). Different 
types of Ca2+ currents are determined by channel variation, which is defined by 
combination between α, β, α2δ and γ subunits isoforms. Due to a more limited 
number of genes encoding subunit sequences in invertebrates as compared to 
vertebrates, a variety of Ca2+ currents is made possible by post-translational 
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modification (e.g. presence of consensus sites for phosphorylation by protein 
kinases), alternate splicing of subunit transcripts (e.g. gene variation at key sites) 
and RNA editing (altered translation at certain sites). All these changes provide 
differences, such as channel kinetics and a presence or lack of motifs which can be 
intracellularly regulated. Since invertebrate α1 subunits possess significant 
sequence similarity with their vertebrate counterparts, the channel they form is still 
referred to as a particular channel group according to the molecular proper
pharmacology can be different (Table 2). 
ties, while 
Ca2+ signaling in invertebrates 
Ca2+ signaling in both vertebrate and invertebrate muscle systems recruits 
both extracellular and intracellular Ca2+ (Wray et al., 2005; Greenberg, 2005). 
Intracellular Ca2+ stores were identified ultrastructurally in jellyfish Polyorchis 
penicillatus (Lin and Spencer, 2001) and some other invertebrates. In flatworm 
muscle the presence of sarcoendoplasmic reticulum (SR) serves as an intracellular 
Ca2+ reservoir, and has been proved by electron microscopy for turbellarians, 
trematodes and cestodes (MacRae, 1963; Silk and Spence, 1969; Lumsden and 
Byram III, 1967). In schistosomes, the presence of ryanodine receptors, which can 
mediate the release of Ca2+ stored in the SR, has been demonstrated by [3H] 
ryanodine binding (Silva et al., 1998). Flatworm muscle fiber SR has been shown to 
possess enough Ca2+ to support muscle contraction elicited by ryanodine channel 
agonist caffeine. Dose-response curves have been provided for free-living flatworms 
D. tigrina and P. littoralis, and the trematode S. mansoni (Day et al., 2000).
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Table 2. Differences in pharmacological separation between L-type and N-type 
voltage-operated Ca2+ channels in vertebrates versus invertebrates. 
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Table 2 
References: 
 L-type N-type 
 
Sensory neurons: 
• L-type blocked by ω-conotoxin GVIA1 
 
Cardiac, skeletal or smooth muscle: 
• L-type not blocked by ω-conotoxin 
GVIA1 
 
 
 
Chick brain: 
• N-type in synaptosomal membranes is 
blocked by ω-conotoxin GVIA2 
 
Frog muscle: 
• N-type in neuromusclular junction is 
blocked by ω-conotoxin GVIA3 
 
Rat brain: 
• Non-L-type in synaptosomal membranes is 
not blocked by ω-conotoxin GVIA4 
 
Mouse muscle: 
• Non-L-type in neuromusclular junction is 
not blocked by ω-conotoxin GVIA5 
 
V 
E 
R 
T 
E 
B 
R 
A 
T 
E 
  
 
Avian neurons: 
N-type? 
• Blocked by ω-conotoxin GVIA6 
• DHP-sensitive6 
 
 
Gastropod Aplysia californica 
Bag cell neurons: 
L-type? 
• HVA, inhibited by nifedipine7 
• not blocked by ω-conotoxin GVIA1 
• Small channel conductance7 
• Not stimulated by DHP-agonists8 
 
 
Squid 
Giant synapse: 
N- or P-type? 
• ω-conotoxin GVIA has no effect9 
• DHP-insensitive9 
• Activated by small depolarizations9 
• Blocked by FTX (funnel-web toxin)10 
 
Cockroach Periplaneta americana 
Skeletal muscle: 
• L-type PAA/DHP-sensitive11 
 
Nervous system: 
L-type? 
• PAA-sensitive/DHP-insensitive11 
• PAA-insensitive12 
 
 
I 
N 
V 
E 
R 
T 
E 
B 
R 
A 
T 
E 
 
 
Fruit fly Drosophila melanogaster 
Brain membranes: 
L-type? 
• DHP- and PAA-binding sites are 
located on separate Ca channels13 
• DHP/PAA-insensitive13 
• PAA-sensitive/DHP-insensitive13 
• DHP-sensitive/PAA-insensitive13 
 
 
(1) McCleskey et al., 1987; (2) Venema et al., 1992; (3) Kerr and Yoshikami, 1984; (4) Suszkiw et al., 
1987; (5) Sano et al., 1987; (6) Aosaki and Kasai, 1989; (7) Strong et al., 1987; (8) Nerbonne and 
Curney, 1987; (9) Charlton and Augustine, 1990; (10) Llinas et al., 1989b; (11) Skeer et al., 1992; 
(12) Blagburn and Sattelle, 1987; (13) Pelzer et al., 1989. 
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Caffeine turned out to be the most potent on S. mansoni muscle with EC50 of 
0.7 mM compared to 3.2 mM and 4.6 mM for D.tigrina and P. littoralis, respectively. 
The sarcoendoplasmic reticulum Ca2+ ATPase (SERCA), a Ca2+ pump which 
removes cytosolic Ca2+ by sequestering it into SR has been characterized in the fruit 
fly D. melanogaster (Váradi et al., 1989), in the crustaceans Artemia franciscana 
(Escalante and Sastre, 1993) and Procambarus clarkii (Zhang et al., 2000), and in 
the flatworm S. mansoni (De Mendonça et al., 1995). 
The presence of voltage-operated Ca2+ channels (VOCCs) in flatworm muscle 
has been demonstrated by contraction studies using depolarization with elevated 
extracellular K+. Specifically, depolarization elicits contraction of muscles from a 
number of different flatworms, and those depolarization-induced contractions are 
blocked by some classical VOCCs blockers (Mendonça-Silva et al., 2006). Further, 
VOCCs currents have been measured using whole-cell patch clamp in both G. 
tigrina (Cobbett and Day, 2003) and Bdelloura candida (Blair and Anderson, 1993), 
and, very recently, in S. mansoni (Mendonça-Silva et al., 2006). The presence of 
VOCCs in S. mansoni is also demonstrated by the identification of cDNAs encoding 
three different α subunits and one β subunit of VOCCs (Kohn et al., 2001; 2001b). 
Although the presence of VOCCs in both free-living and parasitic flatworms has 
been evident from molecular data, it has been difficult to record the inward currents 
carried by these channels, and even more difficult to perform experiments 
investigating the pharmacology of these important channels. 
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Experiments proposed to characterize the pharmacology of whole isolated 
flatworm muscle fiber membrane inward currents pose a challenge since these 
inward currents rapidly run down. As with VOCCs in all cells, there is often a rapid 
decrement in the amplitude of inward currents soon after the whole cell configuration 
is obtained. In these small muscle fibers of flatworms that rapid rundown is dramatic 
and presents a challenge to measuring the effects of putative blockers and thus their 
pharmacological characterization. 
VOCCs in the skeletal muscle of crustaceans provide Ca2+ influx required for 
tension generation (Caputo and Dipolo, 1978). Some studies showed that Ca2+ influx 
is sufficient to account for tension development (Atwater et al., 1974), while others 
say that Ca2+ influx mainly serves to trigger the release of Ca2+ from the SR 
intracellular stores that activates the contraction – Ca2+-induced Ca2+ release (CICR) 
(Caputo and Dipolo, 1978; Mounier and Goblet, 1987). In crustacean skeletal 
muscle CICR is proposed to be the mechanism of excitation-contraction coupling 
(Györke and Palade, 1992). Unlike in other arthropod skeletal muscles, the 
superficial abdominal flexor muscle of the crustacean Atya lanipes is electrically 
unexcitable (Monterrubio et al., 2000; Bonilla et al., 1992). When depolarized they 
do not develop graded potentials or Ca2+ spikes of all-or-none type, while they are 
dependent on some extracellular Ca2+ to trigger contraction. Even in the conditions 
that suppress outward conductance depolarization-induced Ca2+ currents are too 
small to be measured (no inward current detected with 138 mM Ca2+). Thus the 
extracellular Ca2+ requirement in the absence of inward voltage-operated Ca2+ 
currents can be explained by employing CICR. These channels were called “silent 
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Ca2+ channels” and the currents with 138 mM Sr2+ and Ba2+ as charge carriers were 
sensitive to DHPs, the blockers of classical voltage-gated Ca2+ channels. 
Ca2+ currents are regulated by neuropeptides 
Invertebrate nervous systems involve a number of different neurotransmitters, 
with regulatory neuropeptides being a major part of it. Neuropeptides are signaling 
molecules that control sensory and motor functions. They act through a variety of 
intracellular mechanisms and generalizations about the pathways they trigger cannot 
be made. 
The first peptide neurotransmitter identified in invertebrates was myotropic 
pentapeptide proctolin RYLPT. It was identified in the hindgut of the cockroach 
Periplaneta americana (Brown and Starrat, 1975). In insects and crustaceans 
proctolin stimulates skeletal and visceral muscle and potentiates nerve-stimulated 
contractions of skeletal muscles (Facciponte et al., 1996; Bartos et al., 1994; Lange, 
2002). It also potentiates depolarization-induced contractions of skeletal muscles 
under current clamp (Erxleben et al., 1995) or in high-potassium solutions (Bishop et 
al., 1987), as well as enhancing contractions triggered by caffeine (Wegener and 
Nässel, 2000). Pharmacological studies on the myotropic actions of proctolin in 
invertebrates showed the involvement of both VOCCs and non-voltage- dependent 
Ca2+ channels (Lange et al., 1987; Hertel and Penzlin 1986; Wilcox and Lange, 
1995). 
The L-type Ca2+ current enhancement can be a good candidate to be a major 
determinant in the potentiation of contractions produced by modulatory 
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neurotransmitters. Studies on proctolin effects on the flexor neuromuscular system 
in the crayfish showed that it alone had no effect on plasma membrane Ca2+ 
channels of the tonic flexor muscle and thus did not induce muscle tension, but 
modulated their activity in response to depolarization and potentiated the 
depolarization-induced tension of the muscle (Bishop et al., 1991). Proctolin 
enhanced influx of extracellular Ca2+ due to increased single-channel open 
probability determined by the reduction of the mean closed time and appeared to 
regulate Ca2+ channels via an intracellular messenger, possibly cAMP. In insect 
oviduct preparation (Holman and Cook, 1985) and cockroach hindgut (Cook and 
Holman, 1985) proctolin response however was relatively unaffected by removal of 
extracellular Ca2+ or addition of Ca2+ channel blockers. Thus plasma membrane 
Ca2+ channels may be not the only means by which proctolin influences muscle 
tension. 
In the mollusk Aplysia californica the contraction amplitude and duration of 
accessory radula closer muscle can be regulated by small cardioactive peptides 
(SCPs), myomodulins and 5-HT (Březina et al., 1994). In a voltage-clamp 
experimental setup, a DHP-sensitive L-type current was enhanced by 5-HT and 
SCPs as well as by elevation of cAMP. Inward current enhancement developed 
within seconds after modulator application, showed no desensitization, was blocked 
in a time-dependent manner by Co2+ and nifedipine (20-50 μM completely eliminated 
the current, while 1 μM affected the current at the end of the voltage step) and was 
practically irreversible. 
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In cockroach Periplaneta americana hyperneural muscle, the peptide seems 
to use mechanisms different from, or in addition to, membrane depolarization to 
induce Ca2+ influx since the VOCC blocker nifedipine only partially blocks the 
response to the peptide as compared to depolarization-evoked contractions 
(Wegener and Nässel, 2000; Lange et al., 1987). It is still not clear to what extent 
proctolin-induced tonic insect muscle contraction is dependent on Ca2+ mobilized by 
inositol-1, 4, 5-trisphosphate (IP3) or CICR. Proctolin myoexcitatory effect was 
blocked by thapsigargin and ryanodine in a tonic insect muscle of Periplaneta 
americana (Wegener and Nässel, 2000). Proctolin has been shown to act through 
involvement of a PLC-activated pathway in foregut of the locust Schistocerca 
gregaria (Hinton and Osborne, 1995) and possibly might act through PKC activation 
(Wegener and Nässel, 2000). The myoexcitatory effect of proctolin seems to employ 
extracellular Ca2+ influx a prerequisite, while intracellular Ca2+ concentration 
increase appears largely to be due to intracellular Ca2+ release. Peptides induce 
Ca2+ influx by an activation or modulation of DHP-sensitive and voltage-independent 
sarcolemmal Ca2+ channels. 
Another large group of invertebrate regulatory neuropeptides are 
FMRFamide-related peptides. These are short peptides, 4-20 amino acids long that 
have a common Arg-Phe-amide C-terminus (FMRFamide-related peptides – FaRPs 
or FLPs). FMRFamide was first identified in the clam Macrocallista nimbosa and was 
shown to be cardioexcitatory and to induce myoexcitatory responses in non-cardiac 
smooth muscle of mollusks (Price and Greenberg, 1977; Greenberg et al., 1983). In 
insects FLPs have potent myotropic effect on both skeletal and visceral muscle 
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(Robb and Evans, 1994; Walther et al., 1984). Besides arthropods and insects, FLPs 
are common in helminths, too. Four FLPs have been isolated and characterized 
biochemically from flatworm species: YIRFamide from Bdelloura candida (Johnston 
et al., 1996), GYIRFamide from Dugesia tigrina and Bdelloura candida (Johnston et 
al., 1995; Johnston et al., 1996), RYIRFamide from Arthurdendyus triangulates 
(Maule et al., 1994) and GNFFRFamide from the cestode Moniezia expanza (Maule 
et al., 1993). Besides isolation from species themselves the search for new FLPs 
candidates includes a genomics approach, when FLPs in particular species are 
predicted from their genome sequence based on genome comparison with other 
species with known FLPs. 
FLPergic neurons innervate almost all muscular systems in helminths, 
responsible for movement, feeding, reproduction and attachment within the host. 
Physiological data on FLPs in flatworms is presented by myoexcitatory effects on 
muscle preparations of turbellarian Procerodes littoralis (Moneypenny et al., 2001), 
trematodes Fasciola hepatica (Graham et al., 1997; Graham et al., 2000; Marks et 
al., 1996) and S. mansoni (Day et al., 1994); and cestode Mesocestoides corti 
(Hrčkova et al., 2002). Since musculature plays an important role in locomotion, 
attachment and feeding as well as in reproduction, it is very attractive as a potential 
target for the drug therapy. The dramatic effects on muscle systems make FLP 
systems potentially good target, but the mechanisms by which they produce these 
effects remain unknown. 
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YIRFamide is very potent in inducing individual muscle contractions in S. 
mansoni. YIRFamide causes contraction of individual muscle fibers in a 
concentration-dependent manner when it is microperfused onto the individual, 
dispersed muscle fibers. The peptide is very potent with EC50 0.1 μM. YIRFamide-
induced contractions are a bit different from those stimulated by depolarization with 
elevated extracellular K+. The FLP-induced contractions are slightly slower at onset 
and lead to more overall smooth pattern of contraction. 
Arthropod FMRFamide-related peptides belong to five subfamilies: 
myosuppressins, N-terminally extended-FLRFamides, -FMRFamides, -RFamides 
and sulfakinins (Aguilar et al., 2004). Cross-phylum activity of some of them was 
tested in Ascaris suum body wall and ovijector muscles and on the dispersed muscle 
fibers turbellarian Procerodes littoralis. Almost all tested peptides modulate A. suum 
muscle in different ways (inhibitory, excitatory and biphasic effect on tension) and 
induced potent contractions of isolated P. littoralis muscle fibers (Mousley et al., 
2004). 
Effects posed by native and non-native nematode FLPs can be subdivided 
into five types of responses, which might be indicative of at least five different FLP 
receptors on the muscle (Moffett et al., 2003). Nematode FLPs showed to be 
myoexcitatory on the muscle activity of parasitic flatworm Fasciola hepatica, while 
flatworm FLPs failed to produce any visible effect on A. suum body wall and ovijector 
muscles (Marks et al., 1997). Since peptides isolated from phylum Arthropoda have 
been shown to be potent on preparations obtained from Nematoda and 
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Platyhelminthes, it can be indicative of possible similarities in the ligand 
requirements for FLP receptors. 
Using antisera raised against vertebrate neuropeptides, the nervous systems 
of flatworms have been shown to possess abundant neuropeptide 
immunoreactivities (Halton and Gustafsson, 1996). Besides FLPs, there are at least 
two more distinct families of neuropeptides in flatworms: peptides of similar size to 
FLPs that lack the carboxy-terminal Arg-Phe-amide (neuropeptide-like proteins – 
NLPs) and neuropeptide Y-like peptides of 36-40 amino acids (neuropeptide Fs – 
NPFs). NPFs structurally analogous to vertebrate neuropeptide Ys have been 
characterized from Moniezia expanza (Maule et al., 1991), Arthurdendyus 
triangulatus (formely Artioposthia triangulata) (Curry et al., 1992), S. mansoni and S. 
japonicum (Humphries et al., 2004) and recently also discovered in the genome of a 
flatworm S. mediterranea (Day, unpublished). 
Another group of arthropod neuropeptides, allatostatins, are potently 
myoactive in arthropods. Allatostatins induce dose-dependent contraction of 
flatworm P. littoralis isolated muscle fibers, while they were shown to be either 
inactive or inhibitory on A. suum body wall and ovijector muscle respectively 
(Mousley et al., 2005). 
Neuropeptides signaling mechanisms 
The signaling mechanism underlying FLPs effects in helminths is still unclear 
(Omar et al., 2007). Many second-messenger systems transduce signals using G-
proteins, which stimulate and inhibit enzymes like adenylate cyclase or 
 26
phospholipase C, leading to elevation or reduction of second messenger levels. To 
date the only identified FLP receptors are FMRFamide-gated sodium channel 
identified in the snail Helix aspersa (Linguegila et al., 1995), orphan FLP GPCR in 
Caenorhabditis elegans (Mertens et al., 2005) and the GPCR, characterized from 
the free-living flatworm Girardia tigrina, GtNPR-1 (Omar et al., 2007). Upon GtNPR-1 
identification, using chimerical G-proteins, the receptor has been shown to couple to 
either Gα i or Gαo pathway, along with a proposed possibility of Gi βγ dimers working 
through stimulation of phospholipase C β (PLCβ)-mediated cascade (Omar et al., 
2007). Genes encoding peptide receptors (GPCRs) in C. elegans genome are 
abundant counting up to 70 genes, with npr-1 being homologous to D. melanogaster 
and the snail Lymnaea stagnalis genes (Geary et al., 1999; McVeigh et al., 2005). In 
nematodes the FLP AF2 is believed to act through a production of cAMP levels of 
which are believed to increase with muscle relaxation and decrease with muscle 
contraction (Geary et al., 1999). In parasitic flatworms, liver fluke Fasciola hepatica, 
GYIRFamide-induced muscle contraction was shown to be PKC-dependent upon 
activation of PLC pathway (Graham et al., 2000), which could be indicative of Gαq 
involvement (Omar et al., 2007). 
Some other neuropeptides have been shown to cause inhibitory action on 
invertebrate muscle. Peptide sequence identical to SchistoFLRFamide was isolated 
and sequenced from the brain and retrocerebral complex of the locust (Peeff et al., 
1994). Studies on biological effects posed by the peptide on the locust oviduct 
visceral muscle have shown that the peptide has potent modulatory effect on the 
muscle. It has been shown to inhibit or significantly reduce spontaneous, proctolin- 
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or high-potassium-induced contractions (Wang et al., 1995). The requirement of 
Ca2+ entry through plasma membrane via VOCCs and ligand-gated Ca2+ channels in 
these types of contractions may suggest these structures to be the point of 
ScistoFLRFamide action (Wang et al., 1995; Lange et al., 1991). Two membrane 
receptors associated with SchistoFLRFamide have been identified (Wang et al., 
1994). The variety of stimuli that can be altered by SchistoFLRFamide implies that it 
can act on excitation-contraction coupling pathway. The exact site of its action is far 
from being clear. 
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SPECIFIC AIMS 
 Parasitic platyhelminths, both flukes and tapeworms, infect a variety of 
vertebrates, including humans and animals. Schistosoma mansoni is a blood fluke 
that inflicts huge morbidity and mortality rates in humans worldwide. The selection of 
existing anthelmintics is quite narrow and there is an ongoing concern that parasites 
are developing resistance to available drugs, making the potential choices even 
fewer. The discovery of a new generation of anthelmintics is at least in part limited 
by the lack of our knowledge of parasite biology and physiology. The platyhelminth 
nervous system is very complex, especially in terms of neurotransmission. 
 Neurotransmission mediated by FMRFamide-like peptides (FLPs) has been 
proposed as a potential drug target for novel anthelmintics. Functional data on 
flatworm FLPs is thus far confined to myoexcitatory action in both free-living and 
parasitic flatworms. Since musculature is very important for locomotion, feeding and 
reproduction, it is reasonable to hypothesize that interfering with FLP signaling 
would compromise the survival of the worms. 
 The overall specific aim of the current project is to broaden our knowledge of 
the physiology and pharmacology of flatworm muscle, including both free-living and 
parasitic species, especially in relation to neuromuscular excitation mediated by 
FLPs. A clear demonstration of the biology and signaling mechanisms involved in 
FLP signaling will validate further studies on FLP receptors and the neuropeptides 
themselves as appropriate drug targets. This research project has three specific 
aims to examine. 
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SPECIFIC AIM 1: TEST THE HYPOTHESIS THAT EXTRACELLULAR Ca2+ IS 
REQUIRED IN MEDIATING FLP-INDUCED RESPONSE IN ISOLATED S. 
MANSONI MUSCLE 
 Different pharmacological agents can elicit myoexcitatory responses in 
flatworm muscle. It is supposed that muscle contraction is dependent on a rise in 
cytoplasmic Ca2+, and that the source of this Ca2+ can be either intracellular (Wray et 
al., 2005) or extracellular (Greenberg, 2005). Flatworm FLPs have been shown to 
potently and specifically induce muscle contraction in flatworms (Day et al., 1994). 
Though FLPs play important roles in the physiology of flatworm muscle, their 
mechanism of action is not understood. Here we propose to test the hypothesis that 
extracellular Ca2+ is required to support FLP-induced contractions. If so, we will try to 
determine the nature of ion channels responsible for the Ca2+ fluxes across the 
sarcolemma by characterizing the pharmacology of the FLP-induced contractions. 
1.1 Test the hypothesis that FLP-induced contractions are dependent on 
extracellular Ca2+ 
1.2 Test the hypothesis that VOCCs are an important conduit for FLP induced 
Ca2+ influx 
1.2.1 FLP-induced contractions in the presence of VOCCs blockers 
1.2.2 Voltage-gated inward whole cell plasma membrane currents in the 
presence of VOCCs blockers 
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1.2.3 FLP-induced changes in voltage-gated inward whole-cell plasma 
membrane currents. 
SPECIFIC AIM 2: TEST THE HYPOTHESIS THAT IN S. MANSONI MUSCLE FLPs 
TRIGGER Ca2+ INFLUX THROUGH INTRACELLULAR SIGNALLING CASCADE 
Functional data on flatworm FLPs are confined to myoexcitatory effects in the 
trematodes S. mansoni (Day et al., 1994), Fasciola hepatica (Graham et al., 2000) 
the monogenean Diclidophora merlangi (Moneypenny et al., 1997), and the 
turbellarians Procerodes littoralis (Moneypenny et al., 2001) and Bdelloura candida 
(Johnston et al., 1995). Preliminary studies completed using F. hepatica muscle 
strips (Graham et al., 2000) and P. littoralis isolated muscle fiber assay (Totten, 
unpublished) provided evidence for the involvement of a G-protein coupled receptor, 
and possibly second messenger pathways involving cyclic adenosine 
monophosphate (cAMP), phospholipase C (PLC), diacylglycerol (DAG) and protein 
kinase C (PKC). The next series of experiments are proposed to characterize 
possible involvement of second messenger pathways between activation of FLP 
receptors and final muscle contraction response. We will try to determine if PLC, 
PKC or/and protein kinase A (PKA) pathways are involved in mediating the response 
to FLPs in S. mansoni muscle. 
We will test how the contraction response and changes in Ca2+ fluxes across 
the sarcolemma are altered in the presence of different inhibitors of intracellular 
signaling cascades enzymes. Upon completion of these sets of experiments we will 
be able to explore the diversity of FLP-activated signaling pathways. 
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2.1 Test the hypothesis that FLP-induced contractions are mediated by 
phospholipase C (PLC) activation 
2.2 Test the hypothesis that FLP-contractions are mediated by PKC activation 
2.3 Test the hypothesis that protein kinase A (PKA) is involved in mediating FLP-
induced contractions. 
SPECIFIC AIM 3: TEST THE HYPOTHESIS THAT A FREE-LIVING FLATWORM, 
SCHMIDTEA MEDITERRANEA, CAN BE USED AS AN AMENABLE MODEL TO 
STUDY S. MANSONI MUSCLE PHYSIOLOGY AND PHARMACOLOGY 
S. mediterranea is a free-living flatworm that has become very popular for 
studies focused on developmental and regeneration biology due to the worms’ 
remarkable regenerative capacity. Further, the worms are very amenable to gene 
silencing by RNA interference. Another advantage is that there is ongoing genome 
project which reveals the presence of functional sequences involved in intracellular 
signaling. Preliminary comparisons between the genomes of S. mansoni and S. 
mediterranea suggest a conservation of many of the elements of muscle biology 
(Zamanian et al., 2007). 
Our objective is to see if S. mediterranea is similar to its parasitic counterpart 
with respect to the general nature of the voltage-gated ion channels present in 
somatic musculature. Here we propose to do a number of electrophysiological 
experiments to see if S. mediterranea possesses a complement of voltage-operated 
ion channels similar to those in S. mansoni in physiological and pharmacological 
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respects. This will validate further use of this much more tractable species for 
experiments elucidating flatworm muscle physiology. 
The presence of voltage-gated outward and inward currents has been 
demonstrated in muscle fibers of Bdelloura candida (Blair and Anderson, 1996), 
Girardia tigrina (Cobbett and Day, 2003) and S. mansoni (Mendonça-Silva et al., 
2006). In all of these cases it was very difficult to perform experiments investigating 
the pharmacology of the inward currents due to the rapid rundown of those currents. 
We have been successful in developing a protocol for examining the effects of 
pharmacological agents on inward currents of flatworms, as is detailed in Specific 
Aim 1. This will allow us to include in this Specific Aim a comparison of the 
pharmacology of the inward currents in the two worms. 
3.1 Test the hypothesis that S. mediterranea muscle possesses outward current 
profile and pharmacology similar to that of S. mansoni 
3.2 Test the hypothesis that S. mediterranea muscle possesses inward current 
profile and pharmacology similar to that of S. mansoni. 
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MATERIALS AND METHODS 
Worms 
S. mediterranea worms were maintained in the dark in fresh autoclaved 
ultrapure water supplemented with planarian salts (mM): NaCl 1.6; CaCl2 1.0; 
MgSO4 1.0; MgCl2 0.1; KCl 0.1; NaHCO3 1.2 (pH 7.0). 
S. mansoni worms were maintained in the mouse host until ready to harvest 
from mouse mesenteric vein 45-60 days post-infection. 
Muscle cell preparation 
 Isolated muscle fibers were obtained from adult S. mansoni and S. 
mediterranea worms using muscle cell digestion protocol daily. 
The isolation medium used during the procedure was based on a modified 
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, USA) to which the 
following chemicals were added (mM): CaCl2 2.2 (5.0 in case of S. mediterranea); 
MgSO4 2.7; glucose 61.1; NaCl 25.7; dithiothreitol 1.0; gentamicin solution (Roche 
Applied Science, USA) 1% (v/v) and serotonin 1 μM (15 μM in case of S. 
mediterranea) (pH 7.4). 
The dissociation medium was isolation medium with added 1 mM 
ethyleneglycol-bis-(b-aminoethyl ether) N, N, N’ N’-tetraacetic acid (EGTA), 1mM 
ethylenediamine tetraacetic acid (EDTA) and bovine serum albumin (BSA) 0.1% 
(w/v). 
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The final medium was BSA-free dissociation medium to which 1 mg/ml 
enzyme papain was added (Roche Applied Science, USA). 
 S. mansoni muscle cell isolation was done at 37 °C. S. mediterranea muscle 
cell isolation was done at room temperature. 
 Live medium sized worms (15-20 pairs of S. mansoni or 5-6 S. mediterranea) 
were rinsed (4x) with isolation medium, and chopped 35-40 times in two directions 
with a razor blade. Resultant worm pieces after rinsing with the same medium (4x) 
were incubated for 30 minutes on shaker table with papain-containing medium (in 
three installments). After this medium was removed and worm pieces washed (2x) 
with isolation medium, they were incubated for an additional 10 minutes in 
dissociation medium. After final wash with isolation medium (2x) worm pieces were 
broken using a Pasteur pipette by forcing them back and forth through the pipette 
orifice. Cell suspension was plated into plastic 35 mm Petri dishes (Corning Inc., 
USA) in the same isolation medium and allowed to settle for one hour at 19 °C. Cells 
were used for contraction studies and electrophysiological recording within six hours 
after plating. Morphological type of isolated S. mansoni muscle fibers previously 
described as frayed (Day et al., 1993) was used in contraction and 
electrophysiological studies. 
S. mansoni isolated muscle fiber contraction studies 
 Observation of isolated muscle fiber contraction was carried out using 
inverted microscope (Nikon Eclipse TS100) attached to a monitor. A TC-324B 
single-channel heater controller (Warner Instrument Corp., USA) was used to 
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preheat Petri dishes with plated fibers 10 minutes before testing and to keep them in 
warm environment throughout the experiment at 37 °C. 
 All tested agonists were delivered using a glass micropipette in the close 
proximity to a cell. Muscle fiber was considered contracted if shortened to less than 
50% of its original length in 20 seconds. 
 For each plate 25-40 muscle fibers were randomly selected and agonists to 
be tested were pressure-ejected through the micropipette. The bathing medium was 
used as a negative control. Only fibers that were not spontaneously active were 
used in experiments. 
Drug preparation and application 
 Chemicals used were purchased from Sigma, except Calphostin C, 
chelerythrine chloride and Ro 31-8220 which were obtained from BIOMOL (BIOMOL 
International, L.P., USA). YIRFamide was obtained from Research Genetics. 
Contraction studies 
 Verapamil, methoxyverapamil, Ro 31-8220 and calphostin C stock solutions 
were made in DMSO. Diltiazem, H-89, MDL-12,330A and chelerythrine chroride 
stock solutions were prepared in water. After further dilution of stock solutions 
DMSO concentration was never higher than 0.1 %. 
 Some experiments required isolation DMEM to be replaced with inorganic 
DMEM (DMI), which had the following composition (mM): KCl 4.1; HEPES 15.0; 
NaCl 82.5; glucose 79.9; CaCl2 3.6; MgCl2 3.3 (pH 7.4). 
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 Depolarization-induced contractions were elicited by high potassium 
concentration solution (25 mM K+), which had the following chemicals added to 
distilled water (mM): potassium gluconate 25.0; HEPES 15.0; NaCl 2.6; sodium 
gluconate 79.5; glucose 40.0; CaCl2 3.6; MgCl2 3.3 (pH 7.4). 
Electrophysiology 
 The standard extracellular bathing solution for electrophysiological recordings 
was (mM): NaCl 130.0; KCl 5.0; CaCl2 2.0; glucose 10.0; MgCl2 1.0; HEPES 20.0 
(pH 7.3). The standard electrode solution composition was (mM): KCl 135.0; HEPES 
10.0; glucose 10.0; EGTA 2.0 (pH 7.3). 
To record inward currents both Ca2+ and Ba2+ were simultaneously used as 
charge carriers. To isolate ICa/Ba the standard extracellular bathing solution 
composition was (mM): HEPES 20.0; MgCl2 1.0; glucose 10.0; NaCl 112.0; KCl 5.0; 
CaCl2 2.0; BaCl2 15.0 (pH 7.3). In inward current pharmacology experiments this 
solution was further referred as ‘control solution’. It was also used as a vehicle when 
drugs needed to be introduced. The electrode solution contained (mM): HEPES 
10.0; MgCl2 2.0; glucose 10.0; CsMethaneSulfonate 130.0; CsCl 20.0; EGTA 10.0 
(pH 7.3). 
All solutions used for electrophysiology were filtered (0.2 μm; Millipore Millex-
GN). About 10 minutes before recording isolation medium was exchanged for 
extracellular bathing solution. 
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Inward currents pharmacology 
For extracellular application of control solution and drug-containing solutions 
a SF-77B Perfusion Fast-Step (Warner Instrument Corp, Hamden, CT, USA) system 
was used. Syringes with solutions were mounted approximately 14 inches over the 
preparation to give the flow rate of approximately 0.5 ml/min. 
VOCCs antagonists (verapamil and diltiazem) were perfused onto patched 
cells. Verapamil and diltiazem were dissolved in distilled water to make stock 
solutions (0.1 M or 0.01M) and diluted in vehicle to obtain the final concentration of 
10 or 100 μM. YIRFamide stock solution (0.01M) was made in distilled water and 
stored at -20 °C. Aliquots were further diluted in the extracellular bathing solution to 
the final concentration of 1 μM. 
To record ICa/Ba high-resistance seals and whole cell access were obtained in 
cells being constantly perfused with the control solution. In control group cells 
remained under the perfusion for the whole length of the trial. In test groups after the 
inward current reached a steady state (1.5 min after the start of the trial) the lines 
supplying perfusion system were switched from control to drug-containing bathing 
solution for the duration of 2.5 minutes followed by washout with control solution. 
Whole cell recording 
Whole-cell recordings were performed using Axopatch 200B (Axon 
Instruments, Inc.) patch clamp amplifier. Experiments were controlled and data 
recorded using pCLAMP software (pCLAMP 8.0) and Digidata 1320 analog-to-digital 
 38
interface (Axon Instruments, Inc.). Currents were amplified, low-pass filtered at 1 
kHz and digitized at 11.111 kHz and stored on a personal computer. 
Patch-clamp pipettes were double-pulled from borosilicate glass capillaries 
(outer diameter 1.2 mm, inner diameter 0.68 mm; World Precision Instruments, Inc., 
USA) using PC-10 Micropipette Puller (Narishige CO., LTD, Japan). Since isolated 
S. mansoni fibers are relatively small (15-20 μM), successful seals and whole-cell 
configuration were obtained using patch electrodes with resistances that usually 
ranged from 15 to 20 MΩ. Because recorded inward ICa/Ba from isolated S. mansoni 
muscle were relatively small (less than 100 pA), series resistance compensation was 
not usually used. Series resistances yielded after break-in were typically less than 
50 MΩ , giving rise to an error in command potential less than 5 mV for 100 pA 
current. In case of S. mediterranea isolated muscle fibers patch electrodes had 
resistances 5-15 MΩ. 
35 mm plastic Petri dishes were used as a recording chamber. S. mansoni 
cells used for the experiments had frayed morphology (as previously described by 
Day et al, 1993) and gigaohm seal formation was most easily obtained with 
contracted fibers. 
All electrophysiological experiments in both S. mansoni and S. maditerranea 
isolated muscle fibers were carried out at room temperature (22-25 °C). 
To record mixed outward currents and tail currents in S. mediterranea muscle 
fibers were voltage-clamped at the holding potential (Vh) of -40 mV followed by a 
corresponding test pulse protocol. 
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To record ICa/Ba the main whole-cell voltage protocol was as follows. Cells 
were depolarized in 10 mV increments from Vh of -70 mV to +60 mV for 200 ms. 
Traces obtained at each voltage were the average of three runs. To perform inward 
currents pharmacology experiments muscle fibers were voltage-clamped at Vh of -70 
mV and depolarized to +20 mV for 200 ms twice every 30 s. 
Leak and capacity currents were assessed and subtracted online from test 
currents using P/3 protocol for outward currents and P/2 protocol for inward currents 
in pCLAMP software. All subsequent data analysis employed averaged leak 
subtracted current values. 
Data analysis 
All contraction data are expressed as mean percentage of fibers contracting ± 
SEM with n equal to a number of plates tested on at least three different 
experimental days. Dose-response data were analyzed using nonlinear regression 
provided by Prism 4.03 software (GraphPad Software Inc., USA). 
For the plotting of graphs, individual peak and sustained leak subtracted 
values from each cell were first normalized with respect to the peak and sustained 
current values at 1.5 min after the start of the trial for this particular cell. Then graphs 
showing baseline current amplitude change during application and after washout of 
drugs were made from the normalized data. 
Patch-clamp data of pharmacology experiments are presented as mean 
normalized current ± SEM with n equal to a number of cells tested during a particular 
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experiment. Prism software was also used to plot normalized currents data in 
electrophysiology experiments. For statistical analysis of VOCCs blockers and 
YIRFamide effect Mann-Whitney test was performed (P value <0.05) using the same 
program package. 
Peak current values used corresponded to peak amplitudes within first 50 ms 
of the 200 ms test pulse by 5 point smoothing. Using this approach applies a 
highpass boxcar filter with a specified lower and upper cutoff range. The specified 
number of smoothing points is used to smooth superfluous aberrations in the data 
before plotting. The sustained current values corresponded to mean amplitudes 
within the last 50 ms of the 200 ms test pulse. 
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RESULTS 
I. FLPs ARE MYOEXCITATORY IN ISOLATED FLATWORM MUSCLE 
A. CONTRACTION STUDIES 
Physiological data on FLPs in flatworms is presented by myoexcitatory effects 
on muscle preparations of turbellarian Procerodes littoralis (Moneypenny et al., 
2001), trematodes Fasciola hepatica (Graham et al., 1997; Graham et al., 2000; 
Marks et al., 1996) and S. mansoni (Day et al., 1994); and cestode Mesocestoides 
corti (Hrčkova et al., 2002). Since FLPs seem to play an important role in the 
physiology of the flatworm, the search for new possible FLP candidates is ongoing. 
Besides biochemical isolation from species the search includes genomics approach, 
when FLPs in particular species are predicted from their genome sequence based 
on genome comparison with other species with known FLPs. A number of FLPs 
have been predicted from genome sequence of flatworms (Table 3). All of the 
neuropeptides listed in Table 3 were tested for their ability to induce contraction of 
isolated S. mansoni muscle fibers (Figure 1). 
 YIRFamide, as previously described, induced individual muscle contractions 
in S. mansoni in a concentration-dependent fashion (Figure 2). When it was 
microperfused onto the individual, dispersed muscle fibers, the peptide was very 
potent with EC50 0.1 μM. Since YIRFamide was the most potent of the peptides 
tested on muscle contraction, it was used for further studies at 1 μM concentration. 
We could also reproduce depolarization-induced contractions using perfusion with 
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elevated extracellular K+. YIRFamide-induced contractions were a bit different from 
those stimulated by depolarization with elevated extracellular K+. The FLP-induced 
contractions were slower at onset and lead to more overall smooth pattern of 
contraction. 
II. EXTRACELLULAR Ca2+ IS REQUIRED IN MEDIATING FLP-INDUCED 
RESPONSE IN S. MANSONI MUSCLE 
A. CONTRACTION EXPERIMENTS 
FLP-induced contractions are dependent on extracellular Ca2+ 
Our approach was to examine the effects of various Ca2+ conditions on the 
FLP-induced contractions using the dispersed muscle fiber contraction assay. 
Three different experimental conditions were used (Figure 3): 
1) Bathing solution as well as perfusion solution with dissolved drugs (YIRFa and 
caffeine) contained inorganic DMEM (DMI) with Ca2+. Ion composition for DMI 
was the following (mM): KCl 4.1; HEPES 15.0; NaCl 82.5; glucose 79.9; CaCl2 
3.6; MgCl2 3.3 (pH 7.4); 
2) Ca2+ was omitted from both tip and bathing solutions; 
3) Ca2+ chelator EGTA was added to the bathing solution to the final concentration 
of 0.5 mM. 
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Table 3. Some of flatworm neuropeptides predicted from genome sequence 
are used in contractions studies. Flatworm neuropeptides presented here are 
predicted from genome sequence. The peptide is denoted in standard single letter 
aa annotation, and the C-terminal “a” represents an amide group.  The peptides with 
names beginning “sm” are from S. mansoni, and those beginning “smed” are from S. 
mediterranea. 
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Table 3 
 smed-nlp-1b ASFVRLa 
smed-nlp-1a SFVRLa 
smed-npl-2 AKYFRLa 
smed-flp-1e QSVFRYa 
smed-flp-1d GSVFRYa 
smed-flp-1c GVAFRFa 
smed-flp-1b SVAFRFa 
smed-flp-1a SSVFRFa 
sm-nlp-1b AFVRLa 
sm-nlp-1a GFVRIa 
sm-flp-1b YTRFVPQRFa 
sm-flp-1a HFMPQRFa 
Peptide name Flatworm Neuropeptide 
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Figure 1. Structure-activity relationship of flatworm neuropeptides. Flatworm 
neuropeptides predicted from genome sequence of S. mansoni and S. mediterranea 
were tested at 1 μM on their ability to contract isolated S. mansoni muscle fibers. 
Peptides are denoted in standard single letter aa annotation, and the C-terminal “a” 
represents an amide group. The peptides names are listed in the Table 1. 
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When Ca2+ was not present in the medium, depolarization-induced 
contractions were reduced from 68±1 % (n=10) in control group to 8±5 % (n=4) in 
test group. A similar picture was observed with FLP-induced contractions, where 
they decreased to 17±4 % (n=9) from 74±1 % (n=14). Caffeine (10 mM)-induced 
contractions were reduced too, but to a smaller extent 77±2 % (n=6) compared to 
controls 95±1 % (n=3). 
When the Ca2+ chelator EGTA was added, depolarization- and YIRFamide-
induced contractions were totally abrogated, while caffeine was still able to stimulate 
contractile activity of the muscles to 67±2 % (n=8). Thus a conclusion can be made 
that cells required extracellular Ca2+ to support muscle contraction in response to the 
peptide, since in the presence of EGTA intracellular Ca2+ stores were available, and 
were still sufficient to produce a contraction response to caffeine. 
Voltage-operated Ca2+ channels are possibly involved in mediating FLP-
triggered Ca2+ influx 
Since Ca2+ fluxes through the plasma membrane are involved in mediating 
the response to FLPs, we tried to determine the nature of the ion channels carrying 
those fluxes and their pharmacology. Our initial hypothesis was that VOCCs are the 
conduit for the Ca2+ influx. We tested this hypothesis using two different approaches. 
Firstly, we examined the ability of exogenous VOCC blockers to inhibit the FLP-
induced contractions and secondly, we examined the ability of VOCC blockers to 
block voltage-gated Ca2+ currents in the muscle fibers using whole cell patch 
clamping.
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Figure 2. Dose-response curve for the FLP YIRFamide-induced contractions of 
isolated S. mansoni muscle fibers. Isolation DMEM was used as the bathing 
medium and to make dilutions of the FLP to specified concentrations. YIRFamide 
was perfused onto individual fibers. Each data point is the mean ± SEM, with n≥3 
plates tested (at least 30 fibers per plate) at each data point. 
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The effect of exogenous VOCC blockers on the ablility of FLPs to produce 
contractions of individual muscle fibers was examined. The following inhibitors were 
tested: 
1) the phenylalkylamine inhibitors, verapamil and methoxyverapamil; 
2) the dihydropyridine inhibitors, nicardipine and nifedipine; 
3) the benzothiazepine inhibitor, diltiazem. 
We performed contraction studies using 1 µM YIRFamide as the stimulant. In 
these contraction studies, DMI was used as the extracellular medium. 15-20 minutes 
prior to stimulation with the FLP, 10 µM or 100 µM of various VOCC blockers were 
added to the DMI incubation medium (Figure 4). While not all VOCC blockers 
inhibited the FLP-induced contractions, some of them did. 
The least potent of the inhibitors tested was diltiazem. Percentage of the 
YIRFa-induced contractions in the control group (77±2 %, n=18) was not significantly 
reduced by diltiazem at 10 μM (69±2, n=6). Its ability to inhibit the contractions was 
more significant at 100 μM, where the contractions were significantly inhibited to 
63±4 % (n=5). Both verapamil and methoxyverapamil were significantly inhibitory at 
10 μM, where they reduced the percentage of fibers contracting (60±3 %, n=6; and 
62±3 %, n=5, respectively). At 100 μM they both further significantly decreased 
percentage of contracting muscles (16±3 % for verapamil, n=5; and 14±3 % for 
methoxyverapamil, n=5). Nicardipine at 10 μM was the most potent of the inhibitors 
tested, where it significantly reduced the percentage of contracting fibers
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Figure 3. The FLP-induced contractions are dependent on the presence of 
extracellular Ca2+. Both depolarization- and FLP-induced contractions are 
abolished in the presence of 0.5 mM extracellular EGTA. Only caffeine, which 
recruits the release of intracellular stores Ca2+, is still capable of contracting isolated 
muscle fibers. Data points for each graph are presented as mean ± SEM % fibers 
contracting with n ≥ 3 tested on at least three different experimental days. Here and 
throughout the text: asterisks denote the statistically significant difference at P<0.05 
for Student’s t test. 
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Figure 4. The sensitivity of YIRFamide-induced contractions to voltage 
operated Ca2+ channel (VOCC) blockers. Each data point is the mean ± SEM, with 
n≥5 for each agent. Drugs were added 15-25 min before testing with 1 μM 
YIRFamide. YIRFamide dilutions were made in DMI. The bathing and dilution 
medium for the drugs was DMI.The ability of VOCC blockers to reduce the 
myoexcitatory response to YIRFamide suggests involvement of VOCCs in mediating 
Ca2+ influx. P<0.05 for Student’s t test (asterisks of the same pattern are related to 
contractions obtained for a particular stimulant in different conditions as compared to 
the control obtained with the same stimulant). 
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(57±4, n=9). At 100 μM nicardipine reduced the percentage of contractions to 22±5 
(n=7). The ability of these blockers to inhibit the contractions produced by 
YIRFamide implicates VOCCs as the pathway for extracelluluar Ca2+ entry in the 
FLP-induced contractions. 
The next series of experiments were proposed to characterize the 
pharmacology of the whole isolated muscle fiber membrane currents and possible 
involvement of channels carrying them in mediating the cellular response to the 
stimulation with YIRFamide. 
B. VOLTAGE-CLAMP EXPERIMENTS 
The profile of voltage-gated currents activated by the depolarization of the 
plasma membrane using whole cell voltage-clamp technique and electrode solutions 
having K+ as a major cation was shown to be dominated by outward current (Figure 
5A). Voltage-step protocol applied to muscles clamped at -40 mV and stepped from -
60 mV to +50 mV in 10 mV increments produced an outward current present at 
potentials positive to -30 mV. Outward current was relatively moderate in amplitude 
and did not show much inactivation within the duration of 200 ms test pulse (Figure 
5B). Maximum currents were observed at depolarization to +50 mV (320±25 pA for 
peak currents and 310±23 pA for sustained currents, n=6). In such conditions no 
inward currents were observed. After changing the holding potential (Vh) of clamped 
muscles from -40 mV to -70 mV along with replacing electrode K+ with Cs+ and 
addition of Ba2+ to the solution it was possible to record whole cell inward currents. 
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Figure 5. Voltage-dependent outward currents mask the inward currents in 
muscle fibers of the parasitic flatworm S. mansoni. (A) An example of traces 
recorded from S. mansoni muscle fibers held at -40 mV using a 200 ms pulse step 
protocol from -60 mV to +50 mV in 10 mV increments (in this figure, traces represent 
non leak-subtracted data). The scale bar is 200 pA. (B) Current-voltage relationship 
for outward currents recorded from S. mansoni muscle. Values for the I-V plot are 
the average of three replicates at each voltage value. Peak current measurements 
were taken by five point smoothing for the 50 ms time span after the start of the test 
pulse and the sustained current values are the mean current amplitude obtained 
within the last 50 ms before the end of the test pulse (in this figure, I-V relationship 
for the outward currents is done for non leak-subtracted currents). 
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We have been able to record whole-cell inward cationic currents in the 
presence of Ca2+/Ba2+ cationic mixture, using whole-cell configuration of the patch-
clamp technique in single-electrode voltage clamp mode. Inward voltage-activated 
current was recorded under conditions that suppressed outward K+ conductance by 
the replacement of internal K+ with Cs+ and enhanced with 15.0 mM Ba2+ as a 
charge carrier in addition to 2.0 mM Ca2+ (ICa/Ba). A voltage step protocol of 200 ms 
duration was executed on individual muscle cells held at -70 mV. Current signals 
were amplified (Axopatch 200B), filtered, digitized and transferred to a personal 
computer. Step depolarizations in 10 mV increments revealed inward currents of 
relatively small size. The inward currents did not show evidence of inactivation within 
the period of the 200 ms depolarizing pulse. 
Pharmacological characterization of VOCCs in both free-living and parasitic 
flatworms has been hindered since the currents carried by these channels are small 
in amplitude and rundown quickly. While the presence of VOCCs in the parasite S. 
mansoni has been evident from molecular data and supported by physiological data, 
their pharmacological characterization has not been performed. 
Under the specified conditions patched cells exhibited the following profiles 
(%): no currents recorded 38; outward currents profile 6; inward currents profile 56. 
Relatively small proportion of cells that showed inward currents profile had currents 
of the amplitudes amenable to pharmacological characterization using common 
VOCC blockers and neuropeptides – 41 %. The dramatic rundown of these inward 
currents soon after the whole cell configuration had been obtained posed a 
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challenge for completing pharmacology experiments using putative blockers and 
neuropeptides. 
To complete this set of experiments the number of depolarizing sweeps in the 
standard voltage-step protocol was reduced to one sweep at the voltage level where 
the largest current amplitude has been typically recorded. Otherwise prolonged full-
scale protocol would have added to acceleration of the current rundown. Since the 
largest current amplitudes were observed at +20 mV, a new protocol with a single 
depolarizing step from a holding potential of -70 mV to +20 mV was used. To obtain 
the relationship between the current amplitude and time, voltage steps were 
executed every 30 seconds. Currents stimulated by the protocol generally reached 
their peak values within the first 1.5 minutes after the start of the trial, then remained 
relatively stable for the next 2.0 - 2.5 minutes, followed by a gradual decline in the 
current amplitude over the next 6.0 - 7.0 minutes (Figure 6). Thus the trial time was 
reduced to cover the 6.5 minutes after whole cell access, a time period in which the 
currents’ behaviour was pretty predictable. Since before running down currents 
remained at the relatively stable level for some time it was possible to apply VOCC 
inhibitors to observe their effect on the channels. By comparing inward currents in 
muscles in which the putative blockers were applied to muscles in which the control 
vehicle was applied it was possible to perform some of the pharmacological 
characterizations of these important channels for the first time. 
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Figure 6. Whole cell voltage-gated ICa/Ba currents of S. mansoni isolated 
muscle fibers evoked by 200 ms depolarizing step to +20 mV from the holding 
potential Vh of -70 mV. (A) A representative ICa/Ba current trace. Scale bar is 20 pA. 
(B) ICa/Ba runs down with time. On average currents reached peak amplitude 1.5 
minutes after the start of the trial and maintained a steady state within next 2.0-3.0 
minutes followed by gradual decline in amplitude. Peak and sustained current values 
were plotted versus time for a typical recording presented in (A). 
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The panel of possible inhibitors to be tested was reduced by their ability to 
remain soluble in the solution containing high concentrations of divalent cations, 
presence of which allows recording the inward currents. One of the inhibitors which 
did not pose such a problem was verapamil, which could be dissolved at 10 μM and 
100 μM in the bathing solution. 
For extracellular application of control and drug-containing solutions a SF-77B 
Perfusion Fast-Step system (Warner Instruments) was used. Obtaining seals and 
whole cell access were performed with the fibers being constantly perfused with the 
control solution. Control group fibers remained under perfusion for the whole length 
of the trial. In test groups after the inward current reached a steady state (1.5 
minutes after the start of the trial) the lines supplying perfusion system were 
switched from control to drug-containing bathing solution for the duration of 2.5 
minutes followed by washout with the control solution. 
Effect of Ca2+ channel blocker verapamil on ICa/Ba 
After being able to routinely record inward currents in the presence of the 
Ca2+/Ba2+ cationic mixture it was possible to perform some pharmacological 
experiments using the phenylalkylamine VOCC blocker verapamil. Effects of the 
drug at 10 μM and 100 μM were tested on its ability to inhibit peak and sustained 
currents. Peak current values were determined by five points smoothing within the 
first 50 ms of the test pulse and sustained current values were obtained as mean 
values within the last 50 ms of the test pulse. For every cell tested peak and 
sustained current values were normalized to those values obtained at 1.5 minutes 
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after the start of the trial, when the inward current typically reached a maximum and 
right before solutions switch. Normalized values were used to compose graphs. 
Verapamil showed to be more potent on sustained than peak currents at both 
concentrations tested (Figure 7). Normalized sustained current values at the 2.5 
minute time point of the trial were significantly reduced to 48±5 % with verapamil 
tested at 10 μM (n=4) and to 20±3 %when tested at 100 μM (n=3) (P<0.05, Mann-
Whitney test) as compared to the control group (n=5) where the amplitude was 
reduced to 96±8 %as a result of rundown (Figure 7B). 
Peak normalized currents values were not significantly reduced by application 
of 10 μM verapamil (65±5 %, P<0.05, Mann-Whitney test), while at 100 μM current 
inhibition was statistically significant to 47±4 % (P<0.05, Mann-Whitney test) as 
compared to the control group where normalized current was reduced to 90±6 % 
(Figure 7A). 
The inhibitory effect of verapamil was reversible. It was very important to 
wash the drug out, since due to the labile nature of ICa/Ba, it could have been 
confusing to distinguish the effect of the inhibitor from the natural rundown. 
Individual current traces for control and test group recordings are shown in Figure 8. 
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Figure 7. Phenylalkylamine Ca2+ channel blocker verapamil reversibly inhibits 
ICa/Ba in S. mansoni isolated muscle fibers. (A) Effect of verapamil on peak ICa/Ba; 
(B) Effect of verapamil on sustained ICa/Ba. For each cell tested, in control and test 
groups, peak and sustained currents were normalized to corresponding current 
values obtained at 1.5 minute after the start of the trial. Data were plotted as mean ± 
SEM. Seals and break-in were performed with cells constantly perfused with control 
solution. Cells remained under the perfusion for the whole length of the trial. Shaded 
box indicates time points where cells were exposed to the drug-containing bathing 
solution (for the test groups) or control solution itself (for the control group). 
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Figure 8. Representative traces of ICa/Ba activated by depolarizing S. mansoni 
muscle fibers from the holding potential Vh of -70 mV to +20 mV by 200 ms test 
pulse in the absence or presence of verapamil (10 μM or 100 μM). Dotted line 
denotes zero current level and the scale bar is 20 pA (traces from different fibers are 
scaled equally). The time scale of the experiment is shown above traces. 
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YIRFamide enhances ICa/Ba in isolated S. mansoni muscle fibers 
The FLP YIRFamide significantly increased the amplitude of both peak and 
sustained currents when tested at 1 μM (P<0.05, Mann-Whitney test) (Figure 9A). At 
2.5 minute time point of the trial in the test group normalized peak and sustained 
currents increased to 190±22 % and 180±21 % (n=7) correspondingly as compared 
to peak and sustained values in the control group (90±6 % and 96±8 %, n=5). The 
effect of the neuropeptide was reversible. Individual current traces showing current 
amplitude enhancement by the FLP are shown in Figure 9B. 
In order to confirm that the verapamil sensitive current was the same one 
amplified by YIRFamide, we tested the effect of co-application. While YIRFamide 
significantly increased current amplitude, its potentiating effect was reduced with 
verapamil being simultaneously present in the perfusion solution at 100 μM (Figure 
10). The normalized peak current amplitude in the group simultaneously treated with 
YIRFamide and verapamil was not significantly different from the control group 
(130±15 %, n=4 as compared to 90±6 %, n=5, correspondingly, Figure 10A). While 
there was still some increase in the current amplitude it was not found significantly 
different (P<0.05, Mann-Whitney test). The normalized sustained current values 
(Figure 10B) were not significantly different from the values in control group (79±10 
% and 96±8 %, P<0.05, Mann-Whitney test). The traces for the cells simultaneously 
treated with 1 μM YIRFamide and 100 μM verapamil are shown in Figure 10C. 
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Figure 9. YIRFamide enhances whole cell voltage-gated ICa/Ba elicited by 200 
ms depolarizing test pulse from the holding potential Vh of -70 mV to +20 mV 
in isolated S. mansoni muscle fibers. (A) Both peak and sustained ICa/Ba 
increased in amplitude upon treatment with YIRFamide (1 μM). YIRFamide was
applied as indicated with the shaded box. Data were normalized as described in 
Figure 7 and plotted as mean ± SEM; (B) Representative traces of I
 
 above traces. 
Ca/Ba before, 
during and after application of the peptide. Dotted line denotes zero current level and 
the scale bar is 20 pA. The time scale of the experiment is shown
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Figure 10. YIRFamide-mediated increase of ICa/Ba in S. mansoni isolated 
muscle fibers was reduced during treatment with the Ca2+ channel blocker 
verapamil. (A) Verapamil (100 μM) reduced the increase of peak ICa/Ba produce
1 μM YIRFamide; (B) The increase in sustained I
d by 
 
 
ve traces. 
Ca/Ba produced by 1 μM YIRFamide
was reduced to a greater extent by 100 μM verapamil. (C) Representative traces of 
ICa/Ba before, during and after treatment with YIRFamide and verapamil. The 
experimental format is identical to that in Figure 7. Data were plotted as mean ±
SEM. Both verapamil and YIRFamide were dissolved in extracellular bathing 
solution and delivered simultaneously during the time span indicated by a shaded 
box. Dotted line denotes zero current level and scale bar is 20 pA. Time scale of the 
experiment is shown abo
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The inability of the neuropeptide to elevate current levels in the presence of 
verapamil to the levels obtained without the blocker confirms VOCCs involvement in 
carrying Ca2+ influx triggered by the FLP. 
III. FLPs TRIGGER Ca2+ INFLUX THROUGH INTRACELLULAR SIGNALLING 
CASCADE 
A. CONTRACTION STUDIES 
Effect of phospholipase C (PLC) inhibitors 
In these studies, the effect of putative blockers of PLC and InsP3-sensitive 
stores blockers on the ability of FLPs to induce individual muscle contraction was 
examined. YIRFamide at 1 μM was used to produce muscle contraction. The DMI 
medium was used as bathing solution to which the drugs were added 20-40 minutes 
before the application of YIRFamide. PLC inhibitor antibiotic neomycin was used in 
the range of the following concentrations: 10 μM, 100 μM, 1 mM and 10 mM (Figure 
11A). Within the range of concentrations tested it did not produce inhibitory effect on 
YIRFamide ability to induce contractions of individual muscles. 
InsP3-sensitive blocker aminoethoxydiphenyl borate (2-APB) was tested at 10 
μM against 1 μM YIRFamide (Figure 11B). 2-APB was not very effective at inhibiting 
contractions, the response was reduced to 69±2 % (n=6) as compared to the control 
group 74±1 % (n=14), though this difference was found to be statistically significant 
(Student’s t test, P<0.05). 
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Figure 11. Effects of phospholipase C (PLC) inhibitor antibiotic neomycin and 
InsP3-sensitive store blocker aminoethoxydiphenyl borate (2-APB) on 
YIRFamide-induced contractions. Contractions were evoked by 1 μM YIRFamide. 
DMI was used as extracellular and dilution medium. Drugs were added 30 minutes 
prior microperfusion. Each data point is mean ± SEM, with n≥4. 
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Effect of protein kinase C (PKC) inhibitors 
YIRFamide myoexcitation at 1 μM was tested in the presence of PKC 
inhibitors. A panel of inhibitors was used: chelerythrine chloride, Ro 31-8220 and 
calphostin C (Figure 12). DMI was used as the extracellular medium to which 
inhibitors were added 20-40 minutes prior microperfusion with the FLP. 
The concentration-response curve for chelerythrine chloride, a potent and 
specific inhibitor of PKC that interacts with the enzyme catalytic subunit with 
IC50=0.7 µM (Herbert et al., 1990), was obtained in series of contraction experiments 
performed with IC50 at 0.66 μM, which fell within the concentration range specific for 
PKC inhibition. 
Ro 31-8220 which is known as a competitive, selective inhibitor for PKC 
(IC50=10 nM) over PKA (IC50=900 nM) and Ca2+/calmodulin-dependent protein 
kinase (IC50=17 µM, BIOMOL International), did inhibit peptide-induced contractions, 
but required a higher concentration. The IC50 for Ro 31-8220 in experiments with 
peptide-induced contractions was 1.54 μM. 
Calphostin C turned out to be the most potent inhibitor of the peptide-induced 
contractions, with IC50 60.6 nM. The 95 % confidence interval for the obtained curve 
IC50 fell within the range of concentrations known to be specific for PKC inhibition 
(50 nM) in other preparations (BIOMOL International). 
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Figure 12. Various protein kinase C (PKC) inhibitors showed different pattern 
of concentration-dependent inhibition of YIRFamide-elicited contractions in S. 
mansoni muscle fibers. Isolated muscle fibers contraction response to 1 μM 
YIRFamide was tested in the presence of cell permeable PKC inhibitors calphostin 
C, chelerythrine chloride and Ro 31-8220. Cells were bathed in isolation DMEM. 
Inhibitors were added 20-40 min prior the experiment. Each data point is mean ± 
SEM, with n≥3. 
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PKC involvement in mediating the muscle contraction response upon 
stimulation with YIRFamide is suggested by the obtained results with PKC inhibitors. 
Three of them showed inhibitory effect with the most potent inhibitor calphostin C 
being active within the specific range of concentrations for PKC inhibition suggest 
PKC involvement in mediating the response triggered by the FLP. 
Effects of adenylate cyclase (AC) and protein kinase A (PKA) inhibitors 
The activity of cAMP-dependent PKA has been shown to be the major 
regulator of Ca2+ influx through some VOCCs. Transmembrane receptors of many 
hormones and neurotransmitters are coupled to AC via G-proteins. Upon receptor 
binding with an agonist the activated G-protein acts on AC by activating or inhibiting 
its enzymatic activity, depending on whether the G protein is stimulatory or inhibitory 
(Gs and Gi, respectively). Gs stimulation of AC results in the conversion of ATP to 
cAMP, which in turn acts on a variety of second effectors, one of which is PKA. 
Phosphorylation by activated PKA can be linked to L-type Ca2+ channels opening 
(Naguro et al., 2004). 
The PKA pathway involvement in mediating peptide-induced contractions was 
tested using two AC inhibitors (MDL 12.330A and SQ 22.536) and two PKA 
inhibitors (H-89 and myristoylated PKA inhibitor, amide 14-22). Responses to 1 µM 
YIRFamide were obtained in the presence of each of the chemicals tested within a 
certain concentration range. 
MDL 12.330A showed concentration-dependent inhibition of contractions to 
YIRFamide (Figure 13). It showed very high potency, gradually inhibiting 
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contractions and totally abolishing them at 10 µM. The IC50 for MDL 12.330A applied 
against peptide-induced contractions was 0.80 μM. 
The response to 1µM YIRFa in the presence of SQ 22.536 was significantly 
inhibited (P<0.05, Student’s t test) (Figure 14). As compared to MDL 12.330A it has 
been reported to have more specific activity towards AC since it is deprived of effect 
on cAMP phosphodiesterase, the action that could mask the inhibitory effect of the 
drug on AC (Lippe and Ardizzone, 1991). The inhibition produced by SQ 22.536 
within the range of concentrations tested (5 nM-50 μM) was somewhat similar in 
extent, which could be ascribed to some non-specific action of the inhibitor in this 
particular case. Thus it was not clear whether AC was involved in mediating the final 
contraction response. In the literature MDL 12.330A has been reported to exert 
some other actions besides AC inhibition, especially those connected with slow type 
VOCCs (Grupp et al., 1980). Since concentration-dependent inhibition of 
YIRFamide-induced contractions was observed with this non-specific AC inhibitor 
MDL 12.330A, it was tested against depolarization- and caffeine-elicited contractions 
too (Figure 13). MDL 12.330A was an effective inhibitor of depolarization-induced 
contractions with a concentration-dependent inhibition, similar to that obtained with 
the peptide. The IC50 in this experiment was 0.71 μM. 
Caffeine-induced contractions were not blocked by MDL 12.330A within the 
concentration range that was inhibitory for depolarization-induced contractions, even 
though at 50 μM it did totally abolished the caffeine-induced contractions. 
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Figure 13. YIRFamide-, depolarization- and caffeine-induced contractions in 
the presence of adenylate cyclase inhibitor MDL 12.330A. Contractions to 1 μM 
YIRFamide and 25 mM [K+] were inhibited by MDL 12.330A in concentration-
dependent manner, while caffeine-induced response was abolished at higher 
concentrations (50 mM). Cells were bathed in isolation medium (DMEM). The 
inhibitor was added 10-25 min before testing. YIRFamide and caffeine were 
dissolved in isolation DMEM and in DMI correspondingly. Each data point is mean ± 
SEM (n≥4 plates prepared on at least three different experimental days). 
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Figure 14. Effect of specific adenylate cyclase (AC) inhibitor SQ 22.536 on 
YIRFamide-induced contractions. Isolation DMEM was used as bathing medium 
to which the drug was added 30-40 prior microperfusion with 1 μM YIRFamide. 
YIRFamide was dissolved in isolation DMEM. Each data point is mean ± SEM, with 
n≥5. 
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The obtained data with the inhibitors were not sufficient to judge on the AC 
being stimulated upon the neuropeptide application. Since the AC inhibitor blocked 
both peptide- and depolarization-induced contractions with similar concentration-
dependence, its action may not be a specific inhibition of the specific pathway linking 
the FLP to the VOCCs. Rather it may be a less specific inhibitor of the energetic 
pathways utilized in contractions in general, and not the FLP-induced contractions in 
specific. 
A common PKA inhibitor H-89 provided concentration-dependent inhibition of 
peptide-induced contractions (Figure 15), which were totally blocked at 100µM, 
which is consistent with the results obtained with contractions, produced by solutions 
with elevated [K+] (Day et al., 1994). Here the IC50 was 5.08 μM. 
In spite of the fact that H-89 has become very popular in signal transduction 
studies there are some limitations of the drug reported in the literature. In a study on 
specificity of different protein kinase inhibitors H-89 has been shown to inhibit eight 
protein kinases at 10 µM, three of which (MSK1, S6K1 and ROCK-II) were inhibited 
with a similar or a greater potency than that for PKA (Davies et al., 2000). To further 
test the involvement of PKA, highly selective PKA inhibitor, cell-permeable 
myristoylated PKI (14-22) amide was used. 
PKI (cAMP-dependent PKA inhibitor heat-stable protein) selectively inhibits 
the free catalytic subunit of the enzyme (Ashby and Walsh, 1972; Glass et al., 1989), 
within nanomolar range in mammalian systems and acts competitively with respect 
to substrate (Whitehouse and Walsh, 1983).
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Figure 15. Common protein kinase A inhibitor H-89 reduced the percentage of 
S. mansoni muscles contracting in response to YIRFamide (1 μM) in dose-
dependent manner. Cells were bathed and YIRFamide dilutions were made in 
isolation DMEM. The inhibitor was added 20-30 min before testing. Each data point 
is mean ± SEM (n≥4 plates prepared on at least three different experimental days). 
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PKI significantly inhibited YIRFamide-induced contractions at 10 μM (21±4, 
n=8) as compared to percentage of muscles contracted in control group (74±1, 
n=14), but this is a concentration too high to be attributed to specific PKA inhibition. 
At 1 nM - 1 μM range the degree of inhibition was pretty similar for different 
concentrations tested. This result shows that in the range from nanomolar to 
micromolar concentrations PKI does not inhibit YIRFamide-induced contractions to a 
large extent (Figure 16). 
In total, the results with AC and PKA inhibitors are equivocal about the role of 
the cAMP pathway in the YIRFamide-induced contractions. While some AC 
inhibitors do inhibit the FLP-induced contractions, they also inhibit depolarization-
induced contractions. So their effect may not be specific. It would be easy to 
attribute that effect to general inhibition of energy production and not as a specific 
link between the FLP and VOCC. Further the inability of PKA inhibitors to produce 
concentration-dependent inhibition as well as similar inhibitory extent obtained for a 
wide range of concentrations can be explained by some other possible effects. It can 
be proposed that elevated levels of cAMP are needed to stimulate energy production 
necessary to support muscle contraction to any of stimulatory agents. To test this 
hypothesis a non-selective PKA inhibitor H-89 was tested on 10 mM caffeine-
induced contractions (Figure 17). H-89 was tested in the 10 nM–100 μM range. It 
reduced the percentage of caffeine-induced contractions beginning at 0.1 μM (79±2, 
n=3 as compared to 91±2 in the control group, n=7) and was relatively potent at 100 
μM (69±5 % contracting, n=4). Thus a conclusion regarding non-specific effect of the 
H-89 inhibitor can be made.
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Figure 16. Effect of highly selective specific protein kinase A (PKA) inhibitor 
cell-permeable myristoylated PKI (14-22) amide on YIRFamide-stimulated 
contractions. Isolation DMEM was used as bathing medium to which the drug was 
added 30-40 min prior microperfusion with 1 μM YIRFamide. YIRFamide was 
dissolved in isolation DMEM. Each data point is mean ± SEM, with n≥5. 
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It’s inhibitory effect on both YIRFamide-induced contractions, as well as on 
caffeine-stimulated contractions, even though different in extent, can serve as an 
indication that indeed it acts on energy producing machine thus depriving the 
muscles of the energy necessary to support the contraction. 
IV. SCHMIDTEA MEDITERRANEA AS A MODEL FLATWORM 
A. MORPHOLOGY 
The isolation procedure yielded numerous muscle fibers amenable for 
electrophysiological studies. Two morphologically distinguished types of fibers were 
present in the preparation (Figure 18). The first type (Figure 18A) to some extent 
resembled crescent type of muscle fibers isolated from S. mansoni (Day et al., 
1993), which had elongated morphology and were relatively large in size (up to 50-
100 μm). This type of fibers was the most abundant in the preparation. The second 
fiber type had very pronounced ‘stick’ morphology and ranged 30-60 μm in size 
(Figure 18B). ‘Stick’ fibers were relatively less common, averaging to less than one 
third of the total cell population. 
B. VOLTAGE-CLAMP STUDIES 
To determine the nature of voltage-gated currents which are activated by the 
depolarization of the muscle fibers, the whole cell voltage-clamp technique was 
employed using an electrode solution which approximates the ionic composition of 
standard intracellular solution. Depolarizing test pulses following a 1s prepulse to -70 
mV from a holding potential of -40 mV induced large outward current which 
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Figure 17. Effect of protein kinase A inhibitor H-89 on caffeine-induced 
contractions. Isolated muscle fibers contraction ability to 10 mM caffeine was 
tested in the presence of PKA inhibitor H-89. The extracellular medium as well as 
the medium to make caffeine dilution was DMI. The drug was added to the medium 
15-20 minutes before testing. Each data point is mean ± SEM, with n≥5. 
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activated around -30 mV (Figure 19B). Peak outward current showed signs of 
inactivation within the duration of the 500 ms test pulse, while the sustained current 
did not. 
The maximum current amplitude was observed at depolarization to +50 mV 
(1100±110 pA for peak and 300±32 pA for sustained currents, n=8) (Figure 19A). In 
these conditions no inward currents were observed. 
The selectivity of this outward current was determined using a fairly standard 
protocol analyzing tail currents (Figure 20). A big depolarizing test pulse followed by 
varied repolarizing post-pulse potentials allows visualization of tail currents as 
channels close upon the repolarization. Tail currents give an opportunity to study the 
direction of current flow at the potentials where channels are normally closed and 
thus to see the point where current changes in direction (reversal or equilibrium 
potential, Erev). Considering selective permeability of the muscle fiber membrane to 
K+ or Cl- ions we calculated the Erev in the standard conditions (5 mM K+ and 141 
mM Cl- in the extracellular medium) and in the experimental conditions, when 
outside K+ and Cl- concentrations were elevated to 34 mM and 170 mM respectively 
(Table 4). Provided the membrane is selective for K+ ions, the calculated equilibrium 
potential Erev changes from -84 mV in standard conditions to -35 mV in experimental 
conditions. If the membrane was selectively permeable for Cl- ions, then the 
calculated Erev shifts from -1 mV to -6 mV. By plotting tail currents values observed 
at different repolarizing potentials in standard and experimental conditions for each 
cell it was possible to obtain values for the observed Erev of the outward current 
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Figure 18. Photographs of isolated S. mediterranea muscle fibers. (A) An 
example of isolated fibers with elongate morphology. This type of fibers was the 
most abundant in the preparation. (B) Photograph of isolated fibers with ‘stick’ 
morphology. Muscle fiber cyton, a cell body which consists of the nucleus and 
cytoplasm, most of the time stayed intact after the isolation procedure. 
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Figure 19. Voltage-dependent outward currents are present in muscle fibers of 
the free-living flatworm S. mediterranea. (A) Current-voltage relationship for 
outward currents using a depolarizing step pulse protocol of 500 ms duration. Test 
voltages ranged from -80 to +50 mV in 10 mV increments. The holding potential was -
40 mV followed by 1 s prepulse to -70 mV. Traces for I-V plot were obtained as the 
average of three runs at each voltage value. Peak current measurements were 
determined by five points smoothing (see Materials and methods section) for the 50 
ms time period after the start of the test pulse and sustained current values were the 
mean current values of the 50 ms time span before the end of the test pulse. (B) An 
example of recorded traces from an isolated muscle fiber. The scale bar is 500 pA. 
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in the two conditions (Figure 20). Average observed Erev in the standard condition of 
-95 mV shifted upon increasing extracellular K+ and Cl- concentrations to -15 mV at 
25 °C. 
The observed Erev change was similar to predicted Erev change in case the 
membrane was solely selective for K+ ions thus giving an indication that the current 
was mostly carried by K+. This selectivity implies possession of a complement of K+ 
channels by S. mediterranea muscle. 
Voltage-gated inward currents 
Recording of voltage-activated inward current was possible in conditions that 
suppressed outward K+ conductance by internal K+ replacement with Cs+ and with 
enhancement with 15.0 mM Ba2+ as a charge carrier in addition to 2.0 mM Ca2+. 
Using depolarizing in 10 mV increments voltage-step protocol from Vh of -70 mV to 
+60 mV mixed inward ICa/Ba current was isolated (Figure 21A). This inward current 
did not show evidence of inactivation within the period of the 200 ms depolarizing 
pulse and was small in amplitude (Figure 21B). Peak current values were 
determined by five points smoothing within the first 50 ms of the test pulse and 
sustained current values were obtained as mean values within the last 50 ms of the 
test pulse. With depolarization, amplitude of evoked currents was increasing with 
maximum current recorded at +20 mV (-53±7 pA for peak and -35±5 pA for 
sustained current respectively, n=9) followed by amplitude decrease with further 
depolarization. These inward currents were very labile running down within first ten 
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Figure 20. Reversal potential Erev for the outward current in S. mediterannea 
muscle fibers is dependent on extracellular [K+]. (A)-(C) The relationship between 
the tail current values and voltages and examples of tail current traces obtained with 
standard solutions composition (trace on the left) and after switching to experimental 
conditions (Table 4) for three individual cells. Current values plotted against voltage 
were obtained by 5 points smoothing (see Materials and methods) for the 20 ms 
period 2 ms after the cessation of the depolarizing test pulse. Graph straight lines 
denote linear regression line through all the points. The point where it crosses the X-
axis represents the current reversal potential, which is altered by changes in [K+] and 
[Cl-]. Current traces shown were activated by different after-pulse potentials of 150 
ms duration following 200 ms depolarizing pulse to +50 mV. The holding potential 
was -40 mV. Dotted line denotes zero current level. The scale bar is 200 pA. (D) The 
full tail protocol. 
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Table 4. Equilibrium potential Erev (mV) of the outward current recorded from 
isolated S. mediterranea muscle depends on the selective permeability of the 
muscle to ions and their extracellular and intracellular concentrations. 
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Table 4 
 
 
Standard solution composition, 
(mM) 
Experimental solution composition, 
(mM) 
Chemicals 
Extracellular Intracellular Extracellular Intracellular 
NaCl 130 - 130 - 
KCl 5 135 34 135 
CaCl2 2 - 2 - 
Glucose 10 10 10 10 
MgCl2 1 - 1 - 
HEPES 20 10 20 10 
EGTA - 2 - 2 
 
 
 
 
 
 
 Standard 
concentrations 
(mM) 
Experimental 
concentrations 
(mM) 
[ion]extracel/[ion
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Figure 21. Voltage-dependent inward currents are present in the isolated S. 
mediterranea muscle fibers. Currents were evoked by a 200 ms depolarizing pulse 
protocol from the holding potential of -70 mV to +60 mV in the presence of 2 mM 
CaCl2 and 15 mM BaCl2. (A) Individual example of mixed ICa/Ba currents present in the 
fibers. Depolarizing voltages were applied in 10 mV increments. Larger depolarization 
produced larger currents. Dotted line denotes zero current level. Scale bar is 40 pA. 
(B) I-V plot for recorded mixed ICa/Ba. Peak current values were determined by five 
points smoothing within the first 50 ms of the test pulse and sustained current values 
were obtained as mean values within the last 20 ms of the test pulse. Current traces 
obtained at each voltage for each cell are the average of three runs. 
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minutes of the recording protocol, thus making experiments on their pharmacology 
very difficult. 
After reducing the main depolarizing protocol to just one step depolarizations 
from Vh to +20 mV which were executed every 30 seconds it was possible to 
generate recordings to determine the inward current time course (Figure 22A) as 
well as perform some pharmacological experiments. Peak as well as sustained 
currents gradually ran down with time, reached their maximum on the 1.5 minute 
after start of the trail, remained relatively stable in amplitude within next 90-150 
seconds and were almost gone by the end of 8.0 minute time span. Thus the trial 
length for performing pharmacology experiments was reduced to have 6.5 minute 
time course. 
Effect of Ca2+ voltage-operated channels (VOCC) blockers on inward currents 
After being able to routinely record inward currents in the presence of 
Ca2+/Ba2+ cationic mixture it was possible to perform some pharmacological 
experiments. Special perfusion system setup was used to deliver drugs on patched 
cells in whole cell configuration. Seals and break-in were obtained with cells being 
constantly perfused with the standard Ca2+/Ba2+ extracellular (control) solution. This 
solution was used while obtaining steady baseline current recording and washouts, 
as well as a vehicle for drugs tested. The variety of VOCCs blockers was limited by 
their water solubility, since hydrophobic drugs were not compatible with the vehicle. 
 107
 
 
 
 
Figure 22. Whole cell voltage-gated ICa/Ba currents of S. mediterranea isolated 
muscle fibers evoked by 200 ms depolarizing step to +20 mV from the holding 
potential (Vh) of -70 mV. (A) Representative current trace. Scale bar is 40 pA. (B) 
Inward mixed ICa/Ba gradually runs down over time. Step depolarization from Vh of -
70 mV to +20 mV was performed every 30 seconds. Peak and sustained current 
values were plotted versus time for a typical recording. On average currents reached 
their maximum on a fourth run 1.5 minutes after the start of the trail and by the end 
of the 8th minute were almost gone. Current trace at each time point is the average 
of two runs. 
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Phenylalkylamine VOCCs blocker verapamil and benzothiazepine VOCCs 
blocker diltiazem were used at 10 μM concentration. Effects of the drugs on peak 
and sustained currents, their time course and individual traces were obtained 
(Figures 23 and 24). For every cell tested peak and sustained current values were 
normalized to those values obtained at 1.5 minute time point after the start of the 
trial, right before solutions switch. 
Normalized peak current amplitudes were neither significantly reduced in the 
group treated with verapamil (91±4 %, n=4), nor in diltiazem treatment group (100±9 
%, n=4) as compared to control group (99±3 %, n=5) at 2.5 minute time point after 
the start of the trial (P<0.05 Mann-Whitney test). 
Verapamil showed to be potent on sustained currents (P<0.05, Mann-Whitney 
test). It reduced normalized sustained current amplitude at 2.5 minute time point to 
39±21 % (n=4) as compared to control group normalized currents measurements 
(96±3 %, n=5). Diltiazem did not produce significant inhibition of sustained 
normalized currents, reducing them to 70±9 % (n=4) at 2.5 minute trial time point. 
As well as in the case of S. mansoni inward currents pharmacology 
characterization, using VOCCs blockers, it was very important to observe currents 
resuming after drug washout to be able to ascribe the current amplitude lowering to 
the action of drugs. In both drug treatments the effect was fully reversible. 
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Figure 23. Effects of phenylalkylamine Ca2+ channel blocker verapamil and 
benzothiazepine Ca2+ channel blocker diltiazem on whole cell ICa/Ba in S. 
mediterranea isolated muscle fibers. For each cell tested at every time point, in 
control and test groups, peak and sustained currents were normalized to their 
current values at 1.5 min after the start of the trial. ICa/Ba peak current values used 
before normalizing corresponded to peak amplitudes within the first 50 ms of the 200 
ms test pulse (determined by five points smoothing), and sustained current values 
corresponded to mean amplitudes within the last 20 ms of the 200 ms test pulse. 
For each cell tested current trace at each time point was the average of two 
runs. Data were plotted as mean ± SEM. During the trial cells were constantly 
perfused with the bathing solution delivered through the perfusion system pipeline. 
Shaded box indicates time points where cells were exposed to the drug-containing 
bathing solution (for the test groups) or control solution itself (for the control group). 
(A) Verapamil and diltiazem did not significantly alter the amplitude of peak ICa/Ba. (B) 
Both blockers reversibly inhibited sustained ICa/Ba. 
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Figure 24. Representative traces of ICa/Ba activated by depolarizing S. 
mediterranea muscle fibers from the holding potential Vh of -70 mV to +20 mV 
by 200 ms test pulse in the absence or presence of verapamil and diltiazem (10 
μM). Dotted line denotes zero current level and time scale of the experiment is 
shown above traces. 
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DISCUSSION 
I. The platyhelminth FMRFamide-like peptide (FLP) YIRFamide is more potent 
myoexcitatory on schistosome muscle than any of the putative FLPs encoded 
in the schistosome genome. FLP amino acid residue composition of the C-
terminal as well as at positions 3 and 4 is crucial for their biological activity. 
FLPs or FMRFamide-like peptides are a large family of neuropeptides 
abundant amongst invertebrates. In invertebrates, FLPs constitute a large family of 
signaling molecules, responsible for muscle contraction (Day et al., 1997; 
Moneypenny et al., 2001; Worden et al., 1995; Mousley et al., 2004), heart beat 
regulation (Price and Greenberg, 1977; Groome et al., 1994; Skerrett et al., 1995), 
ion channel function (Cottrell, 1990; Green et al., 1994; Cottrell, 1997) and synaptic 
transmission (Skerrett et al., 1995). 
The FLP YIRFamide, isolated from the marine turbellarian Bdelloura candida 
(Johnston et al, 1996), is very potent at inducing contraction of isolated S. mansoni 
muscle fibers. It contracts 80±5 % of muscle fibers when tested at 1 μM. We also 
tested the myoexcitatory ability of a number of putative FLPs, identified from the 
genomes of S. mansoni and a model flatworm, S. mediterranea (Table 3). They 
were tested at 1 μM concentration, where YIRFamide served as a positive control. 
The principal structural difference of the tested peptides was in the C-terminal amino 
acid composition. Based on this criterion they were divided into four different groups 
(Figure 1): peptides ending with RFamide (Arg-Phe-amide), RYamide (Arg-Tyr-
amide), RLamide (Arg-Leu-amide) and RIamide (Arg-Ile-amide) at the C-terminal. 
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Contractions posed by FLPs discovered in flatworm genomes were 
qualitatively different from those observed with YIRFamide. They were very slower 
at the onset, seemed less complete, and resembled some twitching rather than 
smooth contraction. Peptides with RYamide end were the least potent in eliciting 
contraction. Smed-flp-1e peptide QSVFRYamide elicited 9±4% of fiber cells 
contracting (n=4) as compared to 80±5% (n=5) responded to YIRFamide. Peptides 
with RIamide and RLamide ending induced relatively low response of muscle fibers 
contracting: GFVRIamide (33±12 %, n=4), AKYFRLamide (30±5 %, n=4) and 
SFVRLamide (13±1 %, n=4). Peptides with RF residues at the C-terminal induced 
contractions of a larger number of isolated fibers as compared to peptides from other 
groups, but not as much as YIRFamide itself. Sm-flp-1b peptide YTRFVPQRFamide 
elicited 36±9 % (n=4) response and sm-flp-flp-1a peptide HFMPQRFamide gave 
34±2 % (n=4) of contracting fibers. It can be concluded that neuropeptides with polar 
amino acids at the C-terminal are very weak at stimulating myoexcitatory response 
in the muscles, while peptides with hydrophobic aromatic amino acids are able to 
trigger a relatively bigger response. 
Amino acid composition of neuropeptides, specifically the C-terminal 
structure, seems to be crucial for their biological activity. Other isolated turbellarian 
RFamide FLPs such as GYIRFamide and RYIRFamide are also potent contractors 
of S. mansoni muscle (Day et al., 1997). Previous studies of S. mansoni isolated 
muscles have shown that replacement of the phenylalanine residue at position 4 
(Phe4) with tyrosine (Tyr4) yielded a peptide (YIRYamide) with greatly decreased 
potency (Day et al., 1997). Truncated analogs (e.g. FRFamide, RFamide) and YIRF 
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free acid (no amide) were shown to be of very low potency or inactive (Day et al., 
1997). Amino acids residues at N-terminal were also shown to play important role in 
the ability of a certain neuropeptides to bind the FLP receptor and subsequently 
produce a response. 
The structure-activity relationships for myoexcitatory neuropeptides were 
similar in the marine turbellarian Procerodes littoralis isolated muscle fibers 
(Moneypenny et al., 2001) and the whole worm preparations of monogenean 
Diclidophora merlangi (Moneypenny et al., 1997). There, YIRFamide and 
GYIRFamide were very potent myoexcitatory agents, while the GYIRFamide analog 
GYIRdFamide was not capable of inducing contraction of the muscle and blocked 
the ability of other peptides to induce them. 
The similar potent effects of FLPs on different flatworm preparations suggest 
that the receptor FLPs acts on can be of similar structure across the phylum and 
requires specific sequence pattern to pose muscle activity.  
In other species structure-activity relationship is of a great importance. In the 
arthropod Limulus polyphemus and crayfish Procambarus clarkii the N-terminal acid 
substitutions are less restrictive than the N-terminal extensions, where the extended 
FLPs (e.g. TNRNFLRFamide and SDRNFLRFamide) were shown to have 
cardioexcitatory activity, while tetrapeptide FLRFamide was inactive on this 
preparation (Groome et al., 1994; Mercier et al., 1991). 
 Since the peptidergic component of parasitic flatworms attracts special 
attention due to potential of new drug target discovery it is of interest how FLPs 
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execute their myoexcitatory action. Not solely the events triggered inside muscle 
cell, but the structural properties of peptides themselves, their distribution and their 
receptor localization are of interest. The diversity of neuropeptides that have been 
isolated and discovered in genomic data can shed the light on structural features 
responsible for a specific action. Sequencing and localization of biologically active 
peptides, as well as investigation of their physiological effects and behavioral roles in 
both vertebrate and invertebrate systems remains one of the important fields of 
research. 
II. FLP-induced contractions of isolated S. mansoni muscle require 
extracellular Ca2+ and use a DHP/PAA-sensitive channel as extracellular Ca2+ 
conduit. 
Flatworm FLPs have been shown to potently and specifically induce muscle 
contraction in flatworms (Day et al., 1994). It is known that muscle contraction is 
dependent on a rise in cytosolic Ca2+, and that the source of this Ca2+ can be either 
intracellular (Wray et al., 2005) or extracellular (Greenberg, 2005). The extracellular 
Ca2+ recruitment by FLPs and the neuropeptide proctolin in inducing muscle 
contraction was shown in molluscan anterior bypass retractor muscle (Kizawa et al., 
1991) and in the hyperneural muscle of the cockroach Periplaneta Americana 
(Wegener and Nässel, 2000). When the extracellular Ca2+ was omitted from the 
bathing medium the contractions were diminished. In the presence of organic Ca2+ 
channel antagonists such as nicardipine, nifedipine and verapamil contractions were 
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reduced, but to a lesser extent, than were contractions induced by depolarization 
with elevated [K+]. 
We performed the series of S. mansoni isolated muscle contraction 
experiments to find out the importance of extracellular Ca2+ in mediating muscle 
contraction response triggered by FLPs. The results provided evidence for the 
crucial role of extracellular Ca2+. In the culture medium with omitted Ca2+, or with 
added Ca2+ chelator EGTA, both YIRFamide-induced contractions and 
depolarization-induced contractions were abolished, thus indicating extracellular 
Ca2+ requirement. At the same time the caffeine-induced contractions were almost 
full scale, thus indicating that the intracellular Ca2+ stores were enough to support 
contractile response if they were recruited by YIRFamide. 
The mechanism of FLP-induced Ca2+ influx across the muscle in the parasite 
is of interest, as well as the signaling mechanisms that trigger it. The channels that 
control Ca2+ entry in other cell types studied so far were shown to be either voltage-
operated Ca2+ channels (VOCCs) or transient receptor potential channels (TRPs) 
(Hofmann et al., 2000). We applied a panel of putative VOCC blockers in contraction 
assays to see whether the contractile response to YIRFamide is altered in their 
presence. Dihydropyridine (DHP) nicardipine and phenylalkyamines (PAA) 
verapamil and methoxyverapamil inhibited the FLP-triggered myoexcitatory 
response, though at relatively high concentrations. The inhibitors failed to reduce the 
percentage of contracting cells when tested at 10 μM, while at 100 μM the response 
was significantly reduced. These results implicated VOCCs as the possible pathway 
 119
for extracellular Ca2+ entry in the FLP-induced contractions in S. mansoni muscle 
fibers. 
III. Voltage-gated Ca2+ currents of the isolated S. mansoni muscle are PAA-
sensitive. 
Previously recordings of voltage-gated inward divalent currents in flatworms 
have been obtained from muscle fibers isolated from a free-living flatworm Girardia 
tigrina (Day and Cobbett, 2003) and a parasite S. mansoni (Mendonça-Silva et al., 
2006). There fibers were clamped at the holding potential of -70 mV and stepped to 
more positive voltages, which produced inward currents in the presence of 
extracellular Ba2+ used as a charge carrier. Recorded currents were relatively small 
in size (0.1-0.3 nA). Pharmacological characterization of flatworm VOCCs that carry 
these important currents has been difficult since the currents are relatively small in 
amplitude and rundown quickly. Day and Cobbett (2003) showed that the time 
course of inward current recorded in the presence of Ba2+ was somewhat variable, 
where after obtaining the whole cell configuration the current amplitude was rising to 
reach its peak amplitude and then gradually declined. The short life-span of the 
current has been a limiting factor in pharmacological experiments. The current 
rundown was not significantly decreased by the application of ATP, GTP or cAMP in 
the electrode solution. 
In the current study we have been able to consistently record inward currents 
carried by VOCCs in isolated S. mansoni muscle fibers using whole cell 
configuration of the patch-clamp technique in voltage-clamp mode. Inward voltage-
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activated current was recorded under conditions that suppressed outward K+ 
conductance by the replacement of internal K+ with Cs+. We also enhanced inward 
currents with 15.0 mM Ba2+ as a charge carrier in addition to 2.0 mM Ca2+ typically 
present in the bathing medium (ICa/Ba). Whole cell ICa/Ba was obtained from frayed 
muscle fibers by depolarizing them for 200 ms from a holding potential of -70 mV to 
more positive potentials. As in the case of G. tigrina, the S. mansoni inward current 
was relatively small in amplitude and was short-lived too. A simplified voltage-step 
protocol with a depolarization step from -70 mV to +20 mV, the voltage at which the 
largest current amplitude was recorded, allowed obtaining a time course of the 
current. On average, currents reached peak amplitude 1.5 minutes after the start of 
the trial and maintained a steady state within next 2.0-3.0 minutes followed by 
gradual decline in amplitude. The time frame when the current maintained the 
steady state was employed for extracellular application of common VOCC blockers 
and neuropeptides. High voltage-activated (HVA) ICa/Ba amenable to 
pharmacological manipulation was present in less than 30 % of patched cells. 
The currents recorded from S. mansoni isolated muscle fibers were sensitive 
to PAA blocker verapamil, which reduced their amplitude in concentration-dependent 
manner. Due to the incompatibility with the vehicle, specifically, the organic blockers 
such as a common DHP nifedipine, precipitated in the high divalent cations, and 
therefore were not tested. Verapamil was effective against the sustained component 
of the current at both 10 μM and 100 μM concentrations tested, while only at 100 μM 
it was able to reduce the amplitude of the peak component of ICa/Ba. 
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Electrophysiological data for most VOCC currents from invertebrates are not 
sufficient to allow sound conclusions about the specific type of channel mediating 
the current to be made. Most invertebrate currents studied so far were of L-type 
(Yeoman et al., 1999). In mammals L-type Ca2+ channels have α1 pore-forming 
subunit and are activated by high voltages and are sensitive to DHPs. Both L- and 
non-L-type S. mansoni α1 subunits have been cloned (Kohn et al., 2001) as well as 
HVA β subunit (Kohn et al., 2001b). The recorded current might then be carried by 
one of these channels. 
The necessity to apply relatively high concentration of the PAA and DHP 
blockers is in accordance with other invertebrate tissue preparations. Decreased or 
lack of sensitivity is observed in both lower and higher invertebrates compared to 
vertebrate L-type channels, which display sensitivity to DHPs and PAAs in the 
micromolar range. For example in the brain cells of a flatworm Bdelloura candida 
(Blair and Anderson, 1993) Ca2+ currents are relatively insensitive to standard panel 
of VOCCs blockers. There the current stimulated by test pulses is relatively 
unaffected by 10 μM nifedipine (15±10 % block) and 10 μM verapamil (31±20 % 
block). The VOCC α1 subunit of jellyfish Cyanea capillata expressed in Xenopus 
oocytes produces current which is not greatly affected by DHP and PAA inhibitors as 
high as 100 μM (Jeziorski et al., 1998): nifedipine, isradipine and verapamil produce 
50, 36 and 42 % of inhibition correspondingly. As compared to α1 sequences of L- 
and non-L-type mammalian HVA channels, the jellyfish α1 is more close to 
neuromuscular L-type VOCC. In the jellyfish Polyorchis penicillatus neurons, HVA 
channels are not sensitive to PAA verapamil, which is not able to block the current in 
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the 50-100 μM concentration range, while DHP nifedipine at 100 μM reversibly 
inhibits the sustained component of the current (Przysiezniak and Spencer, 1992). In 
invertebrate neurons Ca2+ currents are sensitive to PAA verapamil and D-600 
(Pearson et al., 1993; Schäfer et al., 1994), while they are not sensitive to DHPs 
(Wicher and Penzlin, 1997; Bickmeyer et al., 1994; Pelzer et al., 1989; Pearson et 
al., 1993). The first increased DHPs sensitivity of Ca2+ currents in invertebrates has 
been reported for molluscan muscles (Jeziorski et al., 1998). 
 The obtained VOCC pharmacology data allow us to make comparison 
between the S. mansoni electrophysiology and contraction assays as well as 
between species in search of similarities, which will allow application of similar more 
tractable model species in further research. 
IV. The FLP YIRFamide enhances the inward current carried by PAA-sensitive 
Ca2+ channels and this Ca2+ current enhancement is reduced in the 
simultaneous presence of PAA VOCC blocker verapamil. 
The effect of FLP YIRFamide on voltage-dependent ICa/Ba was studied in 
isolated S. mansoni muscle fibers. YIRFamide at 1 μM produced significant increase 
in the amplitude of both peak and sustained components of the current. The current 
amplitude increase caused by the YIRFamide occurred almost immediately, and 
reached its maximal level within a minute of constant application. This effect was 
reversed by washout. The enhancing effect of YIRFamide on ICa/Ba was reduced in 
the simultaneous presence of a putative PAA L-type channel antagonist verapamil at 
100 μM. The obtained result indicates possible involvement of VOCCs in carrying 
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Ca2+ influx triggered by the FLP. Additional studies will be required to study 
macroscopic whole cell currents in the presence of PLC, PKC and PKA inhibitors. 
Also experimental work at the single channel level would be of interest to see how 
single channel events influence the current. 
V. The signal transduction pathway between GPCR and final contraction 
response of isolated S. mansoni muscle triggered by FLPs is equivocal. 
Of great interest is the intracellular mechanism that links the FLP receptor 
activation and final contractile response. Modulation of Ca2+ channels by 
neuropeptides requires activation of G-protein-dependent signaling cascades 
(Dolphin, 1995; Kits and Mansvelder, 1996) or direct gating of channels (Cottrell, 
1997). In mollusks their modulation by transmitters is mediated by phosphorylation 
via protein kinase A (PKA) or protein kinase C (PKC) pathways, which enhance Ca2+ 
channels. Negative channel regulation occurs directly through G proteins or by 
activation of phosphodiesterases and phosphatases by cGMP (Kits and Mansvelder, 
1996). Previous studies done on a free-living flatworm Procerodes littoralis (Totten, 
unpublished) and liver fluke Fasciola hepatica (Graham et al., 2000) provided 
evidence for the involvement of G-protein coupled receptor, cyclic adenosine 
monophosphate (cAMP) and activation of PLC, protein kinase C (PKC) second 
messenger pathways in mediating the myoexcitatory cellular response to stimulation 
with the FLP GYIRFamide. 
We conducted a series of contraction experiments in order to get more 
knowledge on signaling mechanisms involved between activation of FLP receptors 
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and the final S. mansoni isolated muscle contraction response. The PKC and PKA 
signaling cascades were of particular interest, since they are the major regulators of 
Ca2+ channels activity. 
Several observations in this study confirm the involvement of PKC in 
mediating FLP-triggered response. This conclusion is based on the observation that 
the contraction response was reduced in the presence of PKC inhibitors with IC50 
specific for the reported PKC inhibition range for some of them. Calphostin C, one of 
the most selective PKC inhibitors, was very potent at inhibiting the response. The 
extremely high specificity of Calphostin C is determined by its ability to bind to the 
phorbol ester/diacylglycerol binding site that is unique to PKC (Bruns et al., 1991). 
Two inhibitors tested, the staurosporine analog Ro 31-8220 and chelerythrine 
chloride were effective at blocking the contractions too, but to a lesser extent. 
However, because these inhibitors are less specific, these data are not as 
conclusive as the Calphostin C results. Ro 31-8220 failed to provide inhibition of 
YIRFamide-induced response in the suggested range of concentrations reported as 
specific for PKC. Ro 31-8220, which acts by competitive inhibition of ATP binding to 
the kinase, was reported to have rather low specificity of action on PKC since this 
ATP binding site is conserved among different members of protein kinases family 
(Hartzell and Rinderknecht, 1996). Chelerythrine chloride that affects translocation of 
PKC from cytosol to plasma membrane belongs to a group of drugs that are not 
widely used as specific PKC inhibitors (Bruns et al., 1991). 
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We also had a set of experiments aimed to investigate possible PKA-
dependent pathway. However, no solid grounds for that were established. We used 
a panel of adenylate cyclase (AC) and PKA inhibitors, which included some very 
specific inhibitors and some that are less specific. A common AC inhibitor MDL 
12.330A was found to be very potent at inhibiting neuropeptide-stimulated 
contractions. The results obtained for MDL 12.330A could not be definitely ascribed 
to inhibitory action on AC, since MDL 12.330A has been reported to exert some 
other action besides AC inhibition. It was reported to reversibly inhibit slow Ca2+ 
current in a voltage-dependent manner in rat anterior pituitary cells at 1 μM (Rampe 
et al., 1987). Also MDL 12.330A was shown to have negative ionotropic effect on the 
isolated guinea pig heart (IC50, 1.1 μM), which was reversible on addition of Ca2+ 
ions (Grupp et al., 1980). Inhibitory action on store-operated Ca2+ entry has also 
been reported for it (van Rossum et al., 2000). Besides the above mentioned 
actions, MDL 12.330A has been reported to have biphasic effects on UDP-
glucoronosyltransferase and glucose-6-phosphatase enzymes’ activity in liver 
microsomal preparations (Guellaen et al., 1978). Due to the broad reported 
spectrum of the inhibitor it might be hard to draw conclusions, since the action might 
not be connected with AC inhibition, but with Ca2+ channels or with transient 
receptor potential channels (TRPs). Similar confusing results were obtained when 
testing MDL 12.330A on F. hepatica muscle strips (Graham et al., 2000). There it 
was considered to be an unsuitable pharmacological tool since GYIRFamide-
induced response was inhibited, while excitatory response to 50 μM forskolin was 
not altered. In addition MDL 12.330A itself stimulated mechanical activity of muscle 
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strips. A more specific AC inhibitor SQ 22.536 did not show dose-dependent 
inhibition pattern of the contractions. 
In the present study it was also hard to judge effects posed by a common 
PKA inhibitor H-89 and cell-permeable myristoylated PKI (14-22) amide PKA 
inhibitor on muscle contractions evoked by 1 μM YIRFamide. H-89 was quite potent, 
suggesting that PKA might be involved, but many other studies have shown that it 
can inhibit a number of other enzymes. In a study on specificity of different protein 
kinase inhibitors H-89 has been shown to inhibit eight protein kinases at 10µM, three 
of which (MSK1, S6K1 and ROCK-II) were inhibited with a similar or a greater 
potency than that for PKA (Davies et al., 2000). H-89 has unspecific effects on 
sarcoplasmic reticulum Ca2+ ATPase (Hussain et al., 1999; Lahouratate, 1997) and 
blocks shaker-type K+ channels (Choi et al., 2001). H-89 has already been shown to 
inhibit depolarization-induced contractions of S. mansoni muscle fibers, while the 
cAMP analogue 8-Br-cAMP did not significantly increase percentage of fibers 
contracting in response to increased [K+] (Day et al., 1994). H-89 failed to block 
excitatory response to cell permeable 8-Br-cAMP in muscle strips from F. hepatica 
too (Graham et al., 2000). 
 The use of highly specific inhibitors of AC and PKA could have provided 
evidence for the involvement of the enzymes in mediating the contraction response 
to YIRFamide. As with SQ 22.536, the inhibitory effect posed by the PKI (12-22) 
amide, was doubtful as being related to inhibition of FLP-activated PKA, since the 
concentration at which it was very effective fell far beyond the range specific for PKA 
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inhibition. As an explanation of the observed effects, the suggestion that elevated 
levels of cAMP are just needed to stimulate energy production, necessary to support 
muscle contraction to any of stimulatory agents, can be used. 
In mammalian system muscle phosphofructokinase (PFK), a crucial enzyme 
in glycolysis, has been shown to be phosphorylated as a result of elevated cAMP 
and activated PKA (Foe and Kemp, 1982; Valaitis et al., 1989; Alves and Sola-
Penna, 2003). PFK kinetics of extracts obtained from different mollusks was shown 
to be modulated by phosphorylation, which increases enzyme activity, and 
dephosphorylation (Michaelidis et al., 1993). Serotonin or cAMP administration 
increases the activity of PFK in the homogenates obtained from F. hepatica 
(Mansour and Mansour, 1962). Serotonin stimulates PFK phosphorylation in F. 
hepatica and Ascaris suum (Kamemoto et al., 1989; Harris et al., 1982). In the foot 
muscle of gastropod Patella caerulea incubation of PFK preparation with cAMP and 
cGMP increased enzyme activity (Lazou, 1991). These considerations in addition to 
the observed inhibitory effect posed by AC inhibitor MDL 12.330A on caffeine-
induced contractions, which do not recruit intracellular signaling cascades, suggest 
the energy supply hypothesis as a possible explanation. 
VI. Schmidtea mediterranea muscle possesses a complement of similar K+ and 
PAA-sensitive Ca2+ channels to S. mansoni muscle. 
 We examined the nature of the ensemble of currents activated by 
depolarization to characterize isolated S. mediterranea muscle. The predominant 
voltage-gated current is a large outward K+ current. The identity of the ions 
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responsible for carrying this outward current was determined by analyzing the so 
called ‘tail’ currents of the outward current - these are the transient currents that 
persist after repolarization of the membrane back toward the resting potential. 
Analyzing tail currents gives an opportunity to study the direction of current flow at 
the potentials where channels are normally closed and thus to see the point where 
current changes in direction, referred to as the reversal potential of the current. 
As mentioned previously, the presence of voltage-gated inward currents 
carried by divalent cations has previously been demonstrated in studies on muscle 
fibers isolated from flatworms B. candida (Blair and Anderson, 1993), G. tigrina 
(Cobbett and Day, 2003) and S. mansoni (Mendonça-Silva et al., 2006). As well as 
in these flatworms, experiments proposed to characterize the pharmacology of 
whole isolated flatworm muscle fiber membrane inward currents posed a challenge 
since these inward currents rapidly run down. As with VOCCs in all cells, there is 
often a rapid decrement in the amplitude of inward currents soon after the whole cell 
configuration is obtained. In these small muscle fibers of flatworms that rapid 
rundown is dramatic and presents a challenge to measuring the effects of putative 
blockers. 
Using the same approach, as when recording inward voltage-gated currents 
in S. mansoni muscle fibers, we have been able to consistently record inward 
currents carried by VOCCs in muscle fibers isolated from the free-living flatworm S. 
mediterranea in the presence of Ca2+/Ba2+ cationic mixture. They are very labile and 
run down within first minutes after obtaining the whole cell configuration as well. A 
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special voltage clamp protocol with reduced number of depolarizing sweeps from the 
holding potential of-70 mV to +20 mV, voltage at which the largest current was 
recorded, has been developed to not only record the currents but also to determine 
the time frame within which application of pharmacological agents is made possible. 
On average currents reach maximum amplitude on the 1.5 min after the start of the 
trial, remain relatively stable in amplitude within next 90 – 150 sec and are almost 
gone by end of 8.0 min time span. Using the SF-77B perfusion Fast-Step system 
from Warner Instrument Corporation we were able to compare inward currents in 
muscles in which the putative blockers are applied to muscles in which the control 
vehicle is applied. The currents were sensitive to classical blockers of vertebrate L-
type Ca2+ channels, phenylalkylamine verapamil and benzothiazepine diltiazem. The 
blockers require relatively high concentrations (>1 μM) and are more effective 
against sustained component of the current in contrast to the peak component. 
The comparison of obtained outward and inward currents profiles in S. 
mansoni and S. mediterranea is of importance, since the similar general nature of 
the complement of voltage-gated ion channels present in the somatic musculature of 
both species can validate further use of this much more tractable species for 
experiments elucidating flatworm muscle physiology. 
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